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Pump dysfunction in hypertensive hypertrophy: Impact of severity of blood pressure 
elevation in patients of African ancestry 
Haroon-ur-Rasheed Abbasi*, Elena Libhaber*, Gavin Norton#, Angela Woodiwiss# and Mohammed R. Essop*
*Division of Cardiology, Chris Hani Baragwanath Hospital, University of the Witwatersrand, Johannesburg, South Africa
# Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, 
University of the Witwatersrand, Johannesburg, South Africa
Background: Hypertensive heart failure in developing communities may be associated with reduced pump function. Whether severity of 
hypertension impacts differently in patients with hypertensive hypertrophy with systolic dysfunction as compared to patients with hypertensive 
hypertrophy with preserved systolic function is not clear. We therefore evaluated the relative impact of blood pressure in patients with left 
ventricular hypertrophy (LVH) with preserved left ventricular systolic function versus patients with LVH with reduced systolic function.
Methods: A single-centre study of 175 Black African patients (55% female, age = 53.1±10.1 years) with moderate to severe hypertension (HT) 
was performed. Using echocardiography, patients were grouped as follows: (1) HT with preserved left ventricular systolic function; and 
(2) HT with reduced left ventricular systolic function. All measurements were made using standard American Society of Echocardiography 
definitions. Low ejection fraction (EF) was defined as <50% using the Simpsons method, LVH as LV mass index >120g/m2 in males and 
>100g/m2 in females. HT was defined as systolic or diastolic daytime ambulatory BP (ABPM) >140mmHg or 95mmHg respectively. Twenty 
eight healthy normotensive subjects served as controls.
Results: There were no observed differences in any measure of blood pressure between patients with reduced EF (31 patients, 18%) and 
preserved EF (144 patients, 82%). The low EF group had significantly more male patients (81% vs 37%) but similar BMI (32.2 vs 30.7).
Conclusion: Blood pressure load and severity are similar in hypertensive patients with and without left ventricular dysfunction. These results 
would implicate factors other than blood pressure as important determinants of left ventricular remodelling in hypertension.
Clinical and echocardiographic follow-up of the isolated left ventricular non-compaction 
(ILVNC) cohort at Chris Hani Baragwanath Hospital
Francois Botha*, Ferande Peters# and Mohammed R. Essop*
*Division of Cardiology, Chris Hani Baragwanath Hospital, University of the Witwatersrand, Johannesburg, South Africa
#Consultant Cardiologist, Chris Hani Baragwanath Hospital, University of the Witwatersrand, Johannesburg, South Africa
Background: Isolated left ventricular non-compaction (ILVNC) is a rare, genetic cardiomyopathy characterised by hypertribeculation of the left 
ventricle due to failure of normal embryonic compaction of the myocardium. Left ventricular systolic dysfunction, ventricular thrombus 
formation with cardiac thrombo-embolism and arrhythmias are frequently encountered. No data is available regarding follow-up of patients 
with ILVNC in Sub-Saharan Africa.
Aim: To describe the characteristics and outcomes of patients diagnosed with ILVNC attending the cardiomyopathy clinic at Chris Hani 
Baragwanath Hospital.
Methods: A prospective study was undertaken evaluating 41 patients at the cardiomyopathy clinic at Chris Hani Baragwanath Hospital during 
January 2010 and March 2012. Clinical assessment, a screening echocardiogram for ventricular clots at four monthly intervals and formal 
research echocardiogram was performed on each patient annually.
Results: Mean follow-up was 12.8 +/- 5.0 months. The mean age was 39 +/-10.7 years at diagnosis. 13 male and 28 female patients. Mean left 
ventricular end diastolic diameter 56.8 +/- 8.6mm and mean ejection fraction 32.2 +/- 12.1%. The major complications at baseline were heart 
failure, 67% were in NYHA class II/III, left ventricular thrombus formation in 11(26%). At follow-up 31.7% were in NYHA II/III heart failure, 
5 (13.1%) patients reported worsening heart failure of which 2 (4.8%) required admission and none had left ventricular thrombi. Warfarin was 
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prescribed in 29% of patients with no bleeding complications. There were 5 deaths: 1 cardiac failure related and 4 sudden cardiac deaths.
Conclusion: At one year follow-up, heart failure and sudden cardiac death remained a significant complication of ILVNC despite standard 
heart failure treatment and meticulous follow-up.
First Melody® valve implantation in Africa
D.G. Buys and S.C. Brown
Department of Paediatric Cardiology, University of the Free State, Bloemfontein, South Africa
Introduction: Congenital heart lesions with abnormalities involving the right ventricular outflow tract will require early surgical repair. Re-
intervention rates in these patients are very high due to outflow tract degeneration. The first percutaneous pulmonary valve was implanted by 
Professor Philipp Bonhoeffer in 2000. This valve was modified to develop the Melody® percutaneous pulmonary valve.
Methods: We describe the first 2 Melody® valve implantations in Africa. This was done in 2 male patients where the primary indication for 
valve implantation was increased right ventricular pressure and pulmonary insufficiency. 
Results: Melody® valve implantation was successful in both patients with reduction of right ventricular outflow tract gradients. Both patients 
had no regurgitation post valve implantation. 
Conclusion: Percutaneous pulmonary valves are safe and effective therapy for right ventricular outflow tract revalvulation. The Melody® valve 
can be implanted with a high success and low morbidity and mortality rates. Conduit lifespan can be extended and re-operation rates can 
be reduced.
Untreated aortic stenosis (AS): guidelines for a tertiary setting
Malcolm Dalrymple-Hay, Ian Cox, Sam Melhuish, Tania Riches and Clinton Lloyd
Derriford Hospital, Plymouth, Devon, United Kingdom
Introduction: We aimed to document the number of untreated patients with severe AS in a tertiary cardiac surgical centre and to establish 
the reasons why a valve intervention was not performed.
Methods: The echocardiography database for one calendar year, 2009 (4 086 studies) was interrogated and all patients with AHA criteria of 
severe AS were analysed.
Results: 530 patients had aortic stenosis, of these 175 were classified as severe. 79 (45%) underwent treatment (75 conventional AVR, 
4 TAVI); of the remainder 4 were lost to follow-up; and 92 (53%) did not have a valve intervention. In the untreated group there were 34 
males and the mean age was 82 years. A cardiologist was involved in 86 of those not treated; 10 were referred for surgery; and 76 were not 
referred. Of the 10 patients referred 2 died on waiting list; 2 awaited interventions; and 6 declined therapies. Of the 76 patients not referred 
in 26 it was decided that the AS was not severe despite only 1 having an aortic valve area >1.0. Of those patients not referred 9 had 
moderate LV function; 12 Dyspnoea; 2 Chest pain; and 3 Pre-syncope. The reasons patients were not referred included patient decision 
(14); reported asymptomatic status (15); symptoms not thought to be due to AS (5); advanced age (30); significant co-morbidity (34); 
limited life expectancy (25); high operative risk (29); and others (33). Review by the aortic stenosis multi-disciplinary team (MDT) supported 
no intervention in only 38 (46%), but review of the remaining 44 patients.
Conclusion: In a tertiary setting a retrospective review suggested a significant number of patients with severe aortic stenosis were not offered 
any valve intervention. We believe to optimise care patients with an echocardiographic diagnosis of severe AS should all be reviewed by an 
aortic valve MDT. 
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Anomalous origin of the right pulmonary artery from the aorta: 
case reports and discussion        
H. Dama
Paediatric Cardiology Fellow, Department of Paediatrics, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, 
Durban, South Africa
 
Four cases of anomalous origin of the right pulmonary artery from the ascending aorta (AORPA) were seen at our hospital over the last 
2 years:
Patient 1 presented at 6 years of age with cardiac failure. Echocardiography showed AORPA, a large PDA and features of pulmonary 
hypertension. Cardiac catheterisation demonstrated established pulmonary vascular obstructive disease which pre-cluded surgical correction. 
He was commenced on Sidenafil and now displays signs of clinical improvement.
Patient 2 presented at 26 days of age with apnoea. Echocardiography showed AORPA, a hypoplastic aortic arch, discrete distal coarctation 
and a large PDA. Surgical correction was performed at 1 month of age. Cardiac catheterisation and balloon dilatation of a re-coarcted 
segment was performed at 9 months of age. He is likely to require repeat intervention in the future.
Patient 3 presented at 23 days of age with cardiac failure. Echocardiography showed AORPA and a PDA. He required prolonged ventilation 
pre-op for sepsis and nosocomial pneumonia. Surgical correction was performed at 3 months of age. He was maintained on Sidenafil post-op 
and was clinically well at last follow-up.
Patient 4 presented at 6 days of age with shock. The diagnosis of AORPA and tubular hypoplasia of the aortic arch was made on echo-
cardiography and confirmed by CT angiography. Clinical course was complicated by persistent nosocomial sepsis and hypotension with his 
condition deemed unsuitable for surgical correction. Intensive care was finally withdrawn after consultation with the family. 
Anomalous origin of a pulmonary artery from the aorta as a major cardiac lesion is rare. Most patients develop early signs of cardiac failure. 
Echocardiographic diagnosis may be challenging. The natural history includes early death and the development of progressive pulmonary 
vascular disease in a significant number of patients. Associated aortic arch abnormalities may worsen the prognosis. Early diagnosis and surgical 
intervention are important in managing these patients. 
Protean manifestations of cardiac hydatidosis
Riaz Suleman Dawood*, Ahmed R. Essop*, Robert W. Girdwood#, Martin J. Sussman# and Mohammed R. Essop*
*Chris Hani Baragwanath Academic Hospital, Milpark Hospital, University of the Witwatersrand, Johannesburg, South Africa
#Milpark Hospital, Johannesburg, South Africa
Introduction: Hydatid disease is a zoonosis caused by the cestode Echinococcus granulosus. It is endemic in certain parts of Sub-Saharan Africa. 
Humans are “accidental” intermediate hosts. Cardiac involvement is rare and not formally described in Southern Africa. Herein we describe 
the clinical, electrocardiographic, echocardiographic and serologic features of the disease and also describe surgical and pharmacologic manage-
ment of four patients presenting with cardiac hydatidosis.
Methods: Retrospective review of case records identified 4 patients with histological confirmation of hydatid disease of the heart from which 
data was abstracted.
Results: All patients were native to Botswana and at some stage resided in rural parts of the country. Three were female and 1 male. Mean 
age was 29 years. Two patients presented with rhythm disturbances, the third with chest pain and the fourth was detected incidentally. Electro-
cardiography confirmed complete heart block in 1 patient and revealed marked repolarisation abnormality in another. Single, well circumscribed 
cystic lesions were seen in all patients on echocardiography. One patient had concomitant hydatid disease of the liver as well as features 
suggestive of detachment of the endocyst from the pericyst (“water lily” sign). Another had features suggestive of daughter cysts being present. 
Two patients had positive serology for Echinococcus granulosus of which 1 also had eosinophilia. All patients underwent cardiopulmonary 
bypass, and cysts were aspirated, with subsequent injection of hypertonic saline and reaspirated followed by excision. One patient required 
implantation of a permanent pacemaker at the time of surgical intervention due to destruction of the conducting system by the disease process, 
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and another required mitral valve replacement subsequently due to severe mitral regurgitation. No hypersensitivity reaction was documented. 
All patients survived to 1 year follow-up. Histology revealed scolices in 2 patients and hooklets in the other patients which are pathognomonic 
for hydatid disease. All patients were treated with albendazole, 1 patient had praziquantel added.
Conclusion: Hydatid disease of the heart is unusual. Presentation is highly variable and requires a high index of suspicion. Echocardiography is 
the most useful investigation. Where appropriate, a combined surgical and pharmacologic approach offers the best clinical outcome.
Defensive coping and subclinical vascular disease risk – associations with autonomic 
exhaustion in Africans and Caucasians: the sympathetic activity and ambulatory blood 
pressure in Africans (SABPA) study
Andrea de Kock*, Leoné Malan*, Mark Hamer# and NicoT. Malan*
*Hypertension in Africa Research Team (HART), School for Physiology, Nutrition and Consumer Sciences, North-West University, 
Potchefstroom Campus, Johannesburg
#Psychobiology Group, Department of Epidemiology and Public Health, University College London, London, United Kingdom
Objective: The defensive active coping response is a recognised cardiovascular risk factor in Africans, especially in men. It is uncertain whether 
autonomic dysfunction might be the underlying cause. We therefore investigated associations between salivary MHPG (3-methoxy-4-
hydroxyphenolglycol), as a marker of sympathetic activity, and subclinical vascular disease risk in defensive coping Africans and Caucasians.
Methods: The Coping Strategy Indicator questionnaire identified participants who preferably utilise defensive coping. Ambulatory blood 
pressure was monitored for 24 hours and carotid intima-media thickness (CIMT) was determined from ultrasound images, as an indicator of 
subclinical vascular disease risk. Salivary MHPG was analysed with high performance liquid chromatography. 
Results: Defensive active coping Africans (n=143) showed overall poorer health than Caucasians (n=148), together with higher self-reported 
stress, alcohol abuse, hypertension, abdominal obesity, and risk of diabetes (p≤0.05). African women demonstrated lower levels of MHPG 
compared with Caucasian women, although no differences in men were found. Furthermore, Africans revealed a trend of increased low grade 
inflammation and glycated haemoglobin which was associated with increased CIMT. There was an inverse association between MHPG and 
CIMT in African men (n=30) with a high risk of subclinical vascular disease [ß=-0.22 (-0.40, -0.03)].
Conclusion: Defensive active coping Africans are more at risk of subclinical vascular disease. When defensive coping fails, sympathetic 
hyperactivity may be followed by autonomic exhaustion and sympatho-adrenal-medullary system desensitisation, resulting in pathology.
Glucose and insulin: emerging metabolic therapy against acute heart failure (AHF)
Gaurang Deshpande, Sandrine Lecour and Lionel H. Opie
Department of Medicine, University of Cape Town, Observatory, South Africa
Purpose: Using an isolated rat heart model to study AHF and recovery, in hearts subject to hypotension, hyperadrenergic stimulus, elevated 
fatty acids and reduced glucose, we aimed to explore the effect of metabolic modulators i.e. high glucose and insulin on functional recovery. 
We hypothesize that glycolysis protects against these adverse effects.
Methods: AHF was induced by reducing perfusion pressure to 20cm H2O and increasing free fatty acids (FFA) to 1.3mM in presence of 
adrenaline (10-8 M) while reducing glucose to 2.5mM. Recovery phase was achieved by a perfusion pressure of 100cm H2O with unchanged 
FFA levels (1.3mM). High glucose (HG) (11.1mM) was tested in both AHF and recovery phase. Insulin was added only in the recovery phase.
Results: In the AHF phase, substrate changes with added adrenaline and hypotension reduced heart rate (HR), left ventricular developed 
pressure (LVDP) and increased diastolic pressure. HG reduced the abnormal diastolic pressure (6.51 ± 0.9 vs 54.5 ± 13.0mmHg; p<0.01) thus 
increasing relaxation. 
Recovery phase: In the recovery phase, with no added adrenaline but high FFA in the perfusate, added insulin increased HR (168.5 ± 34.5 BPM 
(beats per minute) vs 36.7 ± 25.0 BPM; p<0.01). LVDP or rate pressure products (RPP) were unchanged. HG throughout both phases 
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improved recovery versus low glucose (LG) (2.5mM). HR recovered (229.6 ± 25.6 vs 36.7 ± 25.0 BPM; p<0.001), RPP was almost 4.3 times 
better in high glucose (in AHF) hearts (p<0.001).
Conclusion: In our model of AHF in the acute phase, HG decreases diastolic pressure. In the recovery phase, both high glucose and insulin 
improve the functional recovery by increasing HR and reducing the diastolic pressure. Thus, glycolysis protects from diastolic dysfunction in 
both phases of AHF.
Williams-Beuren syndrome and Ebstein’s anomaly variant: a rare association
Adele Dippenaar, Lungile Pepeta and Samina Mahmud Yakoob
Division of Paediatric Cardiology, Dora Nginza Hospital, Port Elizabeth Hospital Complex, Walter Sisulu University, 
Port Elizabeth, South Africa 
Background: Williams-Beuren syndrome (WBS), is rare (1:10 000 to 1:50 000) and is caused by a hemizygous contiguous gene deletion on 
chromosome 7q11.23 encompassing the elastic gene (ELN) and 25-35 other genes, all of which is detectable by fluorescent in situ hybridi-
sation (FISH). It is characterised by multiple anomalies including typical facial dysmorphism, congenital heart defects, growth deficiency, mental 
retardation, a-typical behavioural profile and occasionally idiopathic infantile hypercalcaemia. Cardiovascular disease presents as elastin 
arteriopathy which is generalised, commonly presenting as supra-valvular Aortic Stenosis (AS) or supra-valvular Pulmonary Stenosis (PS). The 
association of this syndrome with Ebstein’s anomaly is very rare. We present our case.
Case presentation: A 15-year-old boy presented as a referral from the adult cardiology services with dysmorphic features, mental challenge 
and suspected acyanotic congenital heart disease for a second opinion. He had been seen as an infant and was lost to follow-up. On 
examination he had the phenotypic features associated with WBS which was subsequently confirmed by FISH. Echocardiogram revealed the 
presence of an Ebsteinoid tricuspid valve with Right Ventricular Non-compaction and severe tricuspid regurgitation. The patient was com-
menced on diuretics and underwent successful surgical repair of his tricuspid valve. He developed transient complete heart block post-
operatively. All anti-failure medication was stopped on follow-up. He remains with mild residual tricuspid valve regurgitation and prolapse of 
the anterior tricuspid valve leaflet.
Conclusion: Congenital intra-cardiac anomalies associated with William-Beuren syndrome are extremely rare. To our knowledge, only 1 case 
of William-Beuren syndrome associated with Ebstein’s anomaly has been reported at our hospital.
Sutureless aortic valve replacement: catheter-based transapical versus 
direct transaortic implantation
Mirko Doss
Department of Thoracic and Cardiovascular Surgery, J.W. Goethe-University, Frankfurt, Germany
Background: Catheter-based aortic valve implantation leaves the calcified native leaflets in the aortic root. Upon valve deployment, they are 
pushed to the side, potentially compromising coronary perfusion, exerting pressure on the conduction system and limiting maximum effective 
orifice area. In this study, we evaluated peri-operative outcomes of an alternative self-expanding sutureless valve that is inserted via a 
conventional aortotomy, allowing for complete debridement of calcified native aortic leaflets and annulus.
Methods: A total of 80 patients were included in the study, all requiring bioprosthetic valve replacement for aortic valve stenosis. In the first 
group 29 patients had isolated catheter-based transapical aortic valve implantation using the Sapien Edwards prosthesis. The second group of 
patients (n=80) had direct transaortic valve replacement, using the self-expandable ATS 3F Enable prosthesis. Implantation of the latter device 
utilized cardio-pulmonary bypass, thus debridement of the calcified native leaflets was possible in all cases. In hospital clinical outcomes, 
echocardiography findings and routine blood laboratory parameters were evaluated. 
Results: Thirty day mortality in the transapical group was 17% versus 11% in the transaortic group. There were 2 conversions in each group. 
There was 1 valve migration, 1 complete heart block and 2 cases of coronary obstruction in the transapical group. Implantation time was 
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8 minutes in the transapical group versus 10 minutes in the transaortic group. There were 4 paravalvular leaks in the transapical group and none 
in the transaortic group.
Conclusion: Aortic valve replacement can be performed safely with both sutureless devices. The transaortic approach adds the advantage of 
allowing for resection of native leaflets and performance of concomitant procedures. Laboratory findings showed elevated creatine kinase MB 
fraction in the transapical group and comparable inflammatory parameters, despite the use of cardio-pulmonary bypass in the transaortic group.
Review of truncus arteriosus cases seen at Chris Hani Baragwanath Academic Hospital: 
a “vanishing syndrome” 
G. Dumani, B. Fourie, P.A. Adams and A.M. Cilliers 
Division of Paediatric Cardiology, Department of Paediatrics and Child Health, Chris Hani Baragwanath Academic Hospital, 
University of the Witwatersrand, Johannesburg, South Africa
Introduction: Truncus arteriosus is an uncommon congenital heart disease characterised by a single arterial trunk with a single semilunar valve 
and supplying blood flow to the aorta, pulmonary arteries and coronary arteries. Associated high morbidity and mortality is secondary to 
pulmonary hypertension and associated complex cardiac lesions.
Methods: Retrospective clinical review of 45 cases between 1978 and 2012 presenting to the Division of Paediatric Cardiology at the Chris 
Hani Baragwanath Academic Hospital. Data related to clinical features, diagnosis, operative procedures, pre-operative and post-operative 
follow-up was collected. 
Results: 45 patients (18 males and 27 females) were diagnosed. The most common presenting features were dyspnoea, tachypnoea, a cardiac 
murmur and congestive cardiac failure. Median age at presentation was 8 weeks. Diagnosis was made with echocardiography in all the patients. 
Patients were classified according to type of truncus arteriosus as follows: 31 had Type 1; 7 had Type 2; 1 had Type 3 and 6 patients were not 
classified. Median time to surgery after diagnosis was 8 weeks: 12 patients had successful surgery; 18 were lost to follow-up pre-operatively; 
and 4 were lost to follow-up post-operatively. 13 patients died pre-operatively while 4 patients died post-operatively.
Conclusion: Mortality is up to 80% in unoperated truncus arteriosus during the first year of life. Early diagnosis with good pre-operative care 
is essential to reduce morbidity and mortality. Morbidity and mortality is related to associate complex lesions. Excellent results are achieved 
with early repair and prevent irreversible pulmonary vascular disease. 
The road to a Fontan and beyond - often a bumpy one: a complicated case of tricuspid 
atresia with a lot of diagnostic and treatment dilemmas
B. Fourie, A.M. Cilliers, P.E. Adams and G.C. Dumani
Division of Paediatric Cardiology, Department of Paediatrics and Child Health, Chris Hani Baragwanath Academic Hospital, 
University of the Witwatersrand, Johannesburg, South Africa
We present a 25-year-old male that was diagnosed at 1 month of age with Tricuspid atresia 1B. This patient has had numerous cardiac 
catheterisations and surgeries. These include a classical left-sided Blalock Taussig shunt in 1987, a modified right-sided bi-directional Glenn 
shunt in 1995 and an internal/external Fontan in 2012. He has also undergone 7 cardiac catheterisations up to this date, 2 of which were 
interventional procedures. He had a balloon angioplasty of a Left Pulmonary Artery stenosis caused by the previous Blalock Taussig shunt in 
2003, followed by a balloon angioplasty of the stenosed classic Blalock Taussig shunt and stenting of the Left Pulmonary Artery stenosis in 
2010. The patient had severe polycythaemia before the Fontan surgery and also complained of right sided parasthesia and dizziness. During 
the Fontan surgery done in 2012 an organised clot was noted within the Left Pulmonary Artery stent with no blood flow distally. This 
obstruction could not be resolved intra-operatively. Further management regarding this left pulmonary artery occlusion remains a dilemma 
post-surgery. The patient currently has a one lung Fontan circulation and despite this he has improved post-operatively with an increase in 
systemic saturations and resolution of his severe polycythaemia.
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The effects of acute ethanolamine administration on isoprenaline-induced myocardial 
infarction in adult Wistar rats
Christie Garson, Asfree Gwanyanya, Kishor Bugarith and Roisin Kelly-Laubscher
Department of Human Biology, Faculty of Health Sciences, University of Cape Town, Observatory, South Africa
Introduction: Cardiovascular stress, such as that due to the synthetic catecholamine, isoprenaline (iso), can induce myocardial infarction (MI). 
Ethanolamine (etn) is a biogenic amine, found in certain food types, that protects the isolated rat heart against ischaemia-reperfusion injury. 
The aim of this study was to investigate the cardioprotective effects of acute etn on iso-induced MI. 
Methods: Male Wistar rats (250-350g) were divided into four groups: Control (saline injections only), iso + etn (iso 67mg/kg, s.c. and etn 
10mg/kg i.p.), iso (67mg/kg, s.c. and a saline injection), and etn (saline injection and 10mg/kg i.p.). Rats were anaesthetised with sodium 
pentobarbitone (60mg/kg, i.p.) and mechanically ventilated with room air. Arterial blood pressure was measured from the right carotid artery 
and the electrocardiogram (ECG) was recorded from surface leads. Infarct size was measured using triphenyltetrazolium chloride (TTC) 
staining and the byproducts of lipid peroxidation were quantified. 
Results: Iso administration significantly increased the infarct size (62.0 ± 3.9%, p<0.001) (mean ± SEM) compared to control rats that displayed 
a background TTC-negative artefact (23.7 ± 2.7%). The heart weight/body weight (HW/BW) ratio was also significantly raised in iso rats 
(4.6 ± 0.1, p<0.001) compared to control rats (3.4 ± 0.02). Iso + etn (5.0 ± 0.2 p<0.05) treated rats displayed significantly greater HW/BW 
ratio compared to iso-treated rats. However, there was no significant difference in infarct size between iso and iso + etn. Iso + etn treated 
rats had a lower death rate (1.9%) compared to iso-treated rats (11.3%). There was a significant increase in the amount of conjugated dienes 
(CD) in iso rats (59.56 ± 2.6μmol/L) compared to control rats (39.9 ± 4.0μmol/L, p<0.05). There was no significant difference in the 
generation of CDs between control and iso + etn treated rats. 
Conclusion: In summary, etn seems to protect the rat from iso-induced MI; however the possibility of increased cardiac hypertrophy needs 
further investigation.
The effects of magnesium administration on isoprenaline-induced acute myocardial 
infarction in adult Wistar rats
Christie Garson, Roisin Kelly-Laubscher, Kishor Bugarith and Asfree Gwanyanya
Department of Human Biology, Faculty of Health Sciences, University of Cape Town, Observatory, South Africa
Introduction: Magnesium (Mg+) is widely used in the treatment of cardiac arrhythmias and hypertensive disorders, but its effects on ischaemia 
remain unclear. The aim of this study was to investigate the effects of acute Mg+ administration on isoprenaline (iso)-induced acute myocardial 
infarction (MI). 
Methods: Male Wistar rats (250 - 350g) were divided into four groups and treated as follows: Control (saline injections only), iso + Mg 
(iso 67mg/kg, s.c. + Mg 270mg/kg i.p.), iso (67mg/kg, s.c. and a saline injection), and Mg (saline injection and 270mg/kg i.p.). Rats were 
anaesthetised 24 hours later with sodium pentobarbitone (60mg/kg, i.p.), mechanically ventilated with room air and electrocardiogram was 
recorded. Left ventricular blood pressure was measured via the right carotid artery. Infarct size was measured using triphenyltetrazolium 
chloride (TTC) staining and quantified as a percentage of the total ventricular area. 
Results: Iso induced an infarct of 70.4 ± 4.0% (mean ± SEM) compared to control rats that displayed a background TTC-negative artefact 
(22.5 ± 1.7%; p<0.001). Mg+ did not change the infarct size in iso-treated rats (61.2 ± 3.4%; p>0.05). Iso decreased the rate of ventricular 
relaxation as indicated by dP/dt min (-5550 ± 220mmHg/s) compared to controls (-7914 ± 502mmHg/s; P<0.01), but did not change the heart 
rate. Mg+ had no effect on dP/dt min in iso-treated rats (-5882 ± 466mmHg/s; p>0.05) or on heart rate. Iso decreased the amplitude of the 
R-wave (0.18 ± 0.03mV, compared to controls 0.58 ± 0.06mV; p<0.001), but had no effect on the S-wave. Mg+ had no effect on R or S-wave 
amplitudes on its own, but decreased the S-wave and not the R-wave in iso-treated rats (S-wave amplitude: -0.06 ± 0.02mV compared to 
controls -0.31 ± 0.08mV; p<0.05 and to iso -0.13 ± 0.07mV; p<0.05). Mg+ increased the loss of body weight in iso-treated rats (-4.3 ± 0.9% 
compared to iso -3.8 ± 0.8%; p<0.01 and 0.6 ± 0.5% for controls; p<0.001) but there were no differences in mortality. 
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Conclusion: Mg+ neither decreases nor increases the size of the iso-induced infarct. However recent studies suggest that body weight loss after 
MI in rats can be used as a marker of early heart failure development. Therefore the increased weight loss induced by Mg+ in this study, may 
indicate adverse effects during its use in cardiac disease treatment.
Overcoming the limitations of current echocardiographic criteria used in the diagnosis of 
subclinical rheumatic heart disease
Philip G. Herbst, Zaheera Cassimjee, Alfonso J.K. Pecoraro and Anton F. Doubell
Division of Cardiology, Department of Medicine, University of Stellenbosch and Tygerberg Hospital, South Africa
Purpose: Current echocardiographic criteria for the diagnosis of subclinical rheumatic heart disease (RHD) have limitations: The 2001 World 
Health Organisation Criteria (WHOC) is based on differentiating pathological from physiological mitral regurgitation (MR). New diagnostic 
criteria were proposed by Marijon et al in 2009, the so-called Combined Criteria (CC), which in addition to the presence of MR includes 
morphological features of the rheumatic valve. However, these criteria do not address the most specific feature of the rheumatic process, 
namely commissural fusion. In this study we test the diagnostic ability of the WHOC and CC, and investigate the utility of adding a commissural 
assessment.
Methods: Patient selection was based on a keyword search of echocardiography reports and inclusion of the first 15 patients fulfilling criteria 
of each of our cohorts: Cohort 1: Mitral stenosis (MS); Cohort 2: RHD as defined by CC but without MS; Cohort 3: Dilated cardiomyopathy 
with leaflet restriction due to mitral valve tethering; Cohort 4: Normal controls. Detailed transthoracic echocardiography was performed 
including a direct and indirect assessment of the mitral valve commissures. We tested the sensitivity and specificity of current WHOC and CC 
to detect RHD against our Commissural Fusion Criteria (CFC) and described and compared the mitral valve commissures in Cohorts 1-4. 
Results: The WHOC demonstrated poor sensitivity in selecting patients with RHD as evidenced by the presence of MS, and poor specificity 
in differentiating non-rheumatic MR. The CC fared better in terms of specificity. The CFC outperformed both the WHOC and the CC in 
sensitivity and specificity.
Conclusion: We demonstrate the limitations of current echocardiographic criteria in diagnosing RHD. Both the WHOC and CC are undermined 
by the inclusion of MR as a criterion. They necessarily exclude all RHD patients without MR, the extreme example being pure 
MS patients and incorrectly include patients with non-pathological MR. The CC showed improved specificity compared to the WHOC by 
inclusion of valve morphology but the exclusion of commissural fusion, the most specific feature of the rheumatic process, weaken these 
criteria. We propose that excluding MR as a diagnostic criterion and including a commissural analysis, will strengthen current criteria.
Cardioprotective and anti-hypertensive effects of Prosopus glandulosa in a 
rat model of pre-diabetes
Barbara Huisamen*, Cindy George*, Daneel Dietrich# and Amanda Lochner*
*Division of Medical Physiology, Department of Biomedical Sciences, Faculty of Health Sciences, University of Stellenbosch, South Africa
#Department of Biomedical Sciences, University of Western Cape, Bellville
Introduction: Obesity and type 2 diabetes present with 2 debilitating complications: hypertension and heart disease. The dried and ground 
pods of Prosopus glandulosa is currently marketed as a food supplement with anti-hypertensive properties in South Africa. We determined 
the efficacy of P glandulosa as an anti-hypertensive agent and its myocardial protective ability.
Methods: Male Wistar rats were rendered (a) pre-diabetic (diet-induced obesity: DIO) or (b) hypertensive (high fat diet: HFD). DIO animals 
were treated with P glandulosa (100mg/kg/day, 8 weeks) and compared to age-matched controls. Hearts were perfused ex vivo to determine 
infarct size. Biometric parameters were determined at time of sacrifice. CIRKO mice were similarly treated with P glandulosa and infarct size 
determined. HFD animals were treated from the onset of the diet or from weeks 12-16, using Captopril (50mg/kg/day) as positive control. 
Blood pressure was monitored weekly.
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Results: DIO rats and CIRKO mice: P glandulosa ingestion significantly reduced infarct size after ischaemia/reperfusion. Proteins of the PI-3-
kinase/PKB/Akt survival pathway were affected in a manner supporting cardioprotection. HFD model: P glandulosa treatment both prevented 
and corrected the development of hypertension, also reflected in alleviation of water retention.
Conclusion: P glandulosa is cardioprotective and infarct sparing as well as anti-hypertensive without affecting the body weight or the 
intraperitoneal fat depots of the animals. Changes in the PI-3-Kinase/PKB/Akt pathway may be causal to protection. Results indicated water 
retention, possibly coupled to vasoconstriction, in the HFD animals while ingestion of P glandulosa alleviated both. Treatment of pre-diabetes, 
type 2 diabetes or hypertension with P glandulosa may have immense beneficial health effects. 
Racial variability in telomere length and risk of coronary artery disease
Sajidah Khan*, Anil Chuturgoon#, Devapragasen Moodley# and Alisa Phulukdaree#
*Department of Cardiology, University of KwaZulu-Natal, Durban, South Africa
#Department of Medical Biochemistry, University of KwaZulu-Natal, Durban, South Africa
Introduction: Shorter telomere length is consistently associated with increased cardiovascular risk and mortality and is thought to precede the 
development of atherosclerotic coronary artery disease (CAD). Subsets of our population are at different ends of the risk spectrum for CAD. 
The risk variance may be due to dissimilar gene pools. Telomere length (TL) is not only determined by cell replication from the ageing process, 
but is also influenced by genetic inheritance and the cumulative effect of exposure to environmental risk factors.
Aim: Investigate the major determinants of TL in a biracial cohort of healthy, young adults extracted from a population with a very high 
prevalence of CAD as well as a low prevalence population.
Method: The study design was cross-sectional with a population-based, random selection of normal, asymptomatic participants matched for 
age and gender. Mean TL was determined from leukocyte DNA through a modified quantitative polymerase chain reaction based-assay and 
reported as the relative telomere/single copy gene (T/S) ratio. Fasting blood samples were collected for lipid profile, insulin levels, systemic 
markers of inflammation and oxidative stress. All participants underwent an oral glucose tolerance test and were subjected to standard 
symptom-based questionnaires, clinical examination and exercise stress test. 
Results: 100 Indian males and 87 Black males (85% ethnic Zulus) with a mean age of 37 years participated. TL was significantly longer in 
the Black cohort with a T/S ratio of 0.89 versus 0.67 in Indians (p<0.0001). There were no significant differences in the number of current 
smokers, BMI, systolic and diastolic blood pressure, levels of HDL-cholesterol and hsCRP between the groups. However, there were signi-
ficant differences in family history of premature CAD (32% Indians) vs 0% (Blacks), measures of abdominal obesity, lipid parameters 
other than HDL-cholesterol and prevalence of Type 2 diabetes and pre-diabetes between the two groups. On multi-variate analysis only 
race (p<0.001) and pre-diabetes (p=0.01) were independently associated with mean TL.
Conclusion: Telomere length was significantly longer in Black Africans compared to Indians in this cohort of healthy young adults, perhaps 
reflecting a genetic susceptibility amongst Indians, and may partly explain the considerable difference in the incidence of CAD between these 
population groups.
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Feline hypertrophic cardiomyopathy associated with the A31P mutation in MYBPC3, 
is caused by production of mutated protein C with reduced affinity between the 
MyBP-C C0C1 domain and actin
Craig Kinnear*, Mia Godiksen#,Tina Nielsen†, Peter Højrup†, Sara Granström#, Inga A. Laursen‡, Jørgen Koch#, 
William J. McKenna◊ and Michael Christiansen**
*Department of Biomedical Sciences, University of Stellenbosch, South Africa
#Department of Small Animals Diseases, Faculty of Life Science, University of Copenhagen, Denmark
†Institute of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark
‡Department of Clinical Biochemistry and Immunology, Statens Serum Institute, Copenhagen, Denmark
◊The Heart Hospital, University College of London, United Kingdom
**Department of Clinical Biochemistry and Immunology, Statens Serum Institute, Copenhagen, Denmark
Introduction: Hypertrophic cardiomyopathy (HCM) is a primary disorder of the myocardium in both man and cat, with serious clinical 
manifestations such as stroke, heart failure and sudden cardiac death. Human and feline HCM (fHCM) are clinically comparable, thus HCM in 
Maine Coon (MC) cat is an animal model of human disease. In MC cats a large proportion (~ 50%) of the fHCM cases have been associated 
with the missense mutation, c.91G>C, in the MYBPC3 gene coding for p.A31P in cardiac myosin binding protein C (cMyBP-C). The mutation 
is located in the NH2-terminal C0C1 domain of cMyBP-C which is believed to interact with actin in the sarcomere. The objective of this study 
was to investigate the pathogenic mechanism of the c.91G>C MYBPC3 mutation associated with feline HCM.
Method: Heart tissue was obtained from MC cats genotyped for the mutation and the presence of the mutated protein was examined by 
SDS-PAGE and mass spectrometry (MS). Yeast-2-hybrid (Y2H) analysis was used to assess the effect of the mutation on the interaction 
between cMyBP-C and actin. The publicly available NMR-based structure of the C0 domain was used to calculate and visualise the conse-
quences of substituting the proline for the alanine residue.
Results: Mass spectrometric analysis revealed expression of mutated cMyBP-C protein in a cat which was homozygous for the mutation. Y2H 
analysis of the interaction between actin and the C0C1 domain in cMyBP-C revealed a 70% reduction in ß-galactosidase activity when the 
mutation was introduced, reflecting a decreased binding as a result of the amino acid substitution. Visualising of the C0 domain showed that 
the substitution of the alanine for a proline in residue 31 was highly energetically unfavourable and resulted in only one hydrogen bond 
(H-bond) within the anti-parallel beta-strand instead of 2 H-bonds for alanine.
Conclusion: The p.31P mutated cMyBP-C is expressed in cardiac tissue and the most likely pathogenic mechanism is interference with the 
assembly of the sarcomere due to reduced binding of the C0C1 domain of cMyBP-C to actin.
 
Two week proanthocyanidin treatment prevents heart failure in a rat model
Maritza Kruger*, Sandrine Lecour# and Neil Davies*
* Hatter Institute for Cardiovascular Research, Department of Surgery, Groote Schuur Hospital and the University of Cape Town, 
South Africa
# Hatter Institute for Cardiovascular Research, Department of Medicine, Groote Schuur Hospital and the University of Cape Town, 
South Africa
Heart failure is a multifactorial syndrome and a leading cause of mortality worldwide (Latronico et al., 2008; Mudd and Kass, 2008). To date, 
many pharmaceutical agents, such as angiotensin converting enzyme inhibitors and beta-blockers have been used to treat cardiac hypertrophy 
and early stages of heart failure. These therapies have proven reasonably effective; however, the incidence of mortality due to heart failure is 
still rising (De Luca et al., 2008; Travares et al., 2008; Tunuguntla 2007). Therefore, there is an important need for alternative therapeutic 
strategies, more specifically, natural therapies that is cost-effective and safe, to prevent or reverse hypertrophy before it develops into heart 
failure. Proanthocyanidolic oligomer supplementation (PCO), a grape seed extract, was shown to be effective in a skeletal muscle model of 
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injury. In this model, PCO supplementation resulted in quicker muscle recovery following a contusion injury, favouring an anti-inflammatory 
state (Myburgh et al., 2011). Considering the positive effects of PCO on muscle recovery, as well as results suggesting that resveratrol, another 
member of the polyphenol family, could limit the occurrence of cardiac hypertrophy (Wojciechowski et al., 2010), the possibility exists that 
PCO might also be beneficial.
In the current study, an osmotic minipump containing isoproterenol (2mg/kg/day), a dual b1-b2-adrenergic receptor agonist, was used to 
induce heart failure. Male Wistar rats (280 - 320g) were orally gavaged with either PCO (20mg/kg/day) or distilled water for 2 weeks prior to 
the subscapular implantation of the pump containing isoproterenol or ascorbate (vehicle). There were 8 animals in each of the 4 groups. After 
7 days, the rats were killed and the heart isolated. Paraffin wax-embedded hearts were sectioned (2um) and stained with haematoxylin and 
eosin for the structural composition of the organs, as well as Massons’ trichrome for fibrosis. An elastic neutrophil marker and a macrophage 
marker, ED1, were used to determine the infiltration of immune cells.
Results indicate that the isoproterenol groups lost significant amounts of weight 1 day (p<0.05) after implantation compared to their controls. 
Histological analysis of hearts showed more damage, cardiomyocyte loss and fibrosis in the isoproterenol group receiving placebo treatment 
(I-PLA) compared to the group receiving PCO supplementation (I-PCO) group. Both groups displayed significantly more fibrosis than their 
respective controls. PCO treatment resulted in better recovery after isoproterenol infusion. 
Role of Toll-like receptor 4 in melatonin-induced cardioprotection
K.T. Lamont, L.H. Opie and S. Lecour
Hatter Institute for Cardiovascular Research, Department of Medicine, Groote Schuur Hospital and the University of Cape Town, 
South Africa
Purpose: Melatonin, at concentration found in wine (+/- 75ng/L), confers cardioprotection against myocardial infarction via the activation of 
the SAFE (survivor activating factor enhancement) pathway that involves tumour necrosis factor (TNF) and signal transducer and activator of 
transcription 3 (STAT-3). However, the mechanism involved in melatonin-induced activation of TNF is unclear. As Toll-like receptors 4 (TLR4) 
can activate TNF in the cells, we propose that activation of the SAFE pathway with melatonin requires the activation of TLR4.
Methods: Isolated male Wistar rat hearts were perfused on a Langendorff system. The hearts were pre-treated with melatonin (75ng/L) with/
without TAK242 (500nM), an inhibitor of TLR4, and subjected to a 30 minute regional ischaemia followed by 2 hour of reperfusion. STAT-3 
cardiomyocyte deficient (STAT3 -/-) mice, TNF deficient mice (TNF -/-) and their respective wildtype littermate controls were pre-treated 
with an activator of TLR4 or lipopolysaccharides (LPS, 0.2mg/kg, ip) 45min prior to an ischaemia/reperfusion insult. Infarct size was determined 
as an endpoint. 
Results: Control rat hearts subjected to ischaemia/reperfusion had an infarct size of 49.3 ± 2.6%. Melatonin reduced the infarct size to 
14.9 ± 1.5% (p<0.001 vs control). This protective effect was abolished in the presence of TAK inhibitor to 31.5 ± 1.4% (ns. vs control). In 
wildtype mice, LPS improved infarct size from 40.6 ± .3.7% (controls) to 16.9 ± 0.9% (p<0.001). However, this protective effect was abolished 
in the STAT-3 -/- and TNF-/- mice.
Conclusion: Our data strongly suggest that TLR4 is required in melatonin-induced cardioprotection. Furthermore, TLR4 may act as an 
important component to activate the SAFE pathway with melatonin. 
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Impact of inappropriate versus absolute or indexed left ventricular mass on 
on-treatment changes and community variations in ejection fraction
Carlos David Libhaber*, Angela J. Woodiwiss*, Muzi J. Maseko*, Olebogeng H.I. Majane*, Aletta Esterhuyse*, 
Richard Brooksbank*, Elena Libhaber#, Pinhas Sareli* and Gavin R. Norton*
* Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology and School of Medicine Faculty of Health Sciences, 
University of the Witwatersrand, Johannesburg, South Africa
# Department of Medicine, Division of Cardiology, School of Medicine, Faculty of Health Sciences, Chris Hani Baragwanath Academic 
Hospital, University of the Witwatersrand, Johannesburg, South Africa
Background: Whether the transition from left ventricular hypertrophy (LVH) to heart failure with a depressed ejection fraction (EF) represents 
a cause-effect relationship is unclear. LV mass (LVM) that exceeds that predicted from work load (inappropriate LVM [LVMinappr]), rather than 
LVH per se may cause a depressed EF.
Methods and results: In 168 mild-to-moderate hypertensives treated for 4 months with anti-hypertensive therapy and in 626 randomly 
selected participants over 16 years of age from a community sample using echocardiography, we assessed whether absolute LVM, LVM index 
(LVMI) or LVMinappr determine EF and the factors independently associated with LVMinappr. With adjustments for LV wall stress(s) and 
other confounders, whilst on-treatment decreases in LVM or LVMI were weakly related to an attenuated EF (partial r=0.17, p<0.05) on-
treatment decreases in LVMinappr were strongly related to increases in EF (partial r=-0.38, p<0.0001)(p<0.0001 for comparison of partial 
r values). Also with adjustments for s and other confounders, in the community sample there was a strong inverse relationship between 
LVMinappr and EF (partial r=-0.41, p<0.0001), effects noted in both normotensives and hypertensives, whilst only modest inverse relations 
between LVM or LVMI and EF were noted (partial r=-0.07 to -0.09, p<0.05-0.09)(p<0.0001 for comparison of partial r values). Although an 
increased LVMI was not associated with a reduced EF (<55%)(p=0.50), a greater proportion of participants with an increased LVMinappr 
had a reduced EF than those with a normal LVMinappr (adjusted odds ratio=6.85, p<0.0001). Obesity (mediated in-part through insulin 
resistance and inflammation [C-reactive protein]) was the principal factor that in-part accounted for variations in LVMinappr.
Conclusion: LVMinappr rather than absolute or indexed LVM is strongly related to changes in on-treatment EF, community variations in EF 
and the presence of a reduced EF. LVH can therefore be viewed as a compensatory change that preserves EF, but when in excess of that 
predicted by stroke work, a pathophysiological process causing a reduced EF.
Potential mechanisms that account for obesity-related decreases in left ventricular 
diastolic function
Carlos David Libhaber*, Gavin R. Norton*, Olebogeng H.I. Majane*, Muzi J. Maseko*, Elena N. Libhaber#, 
Mohammed R. Essop#, Pinhas Sareli* and Angela J. Woodiwiss*
* Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology and School of Medicine Faculty of Health Sciences, 
University of the Witwatersrand, Johannesburg, South Africa
# Department of Medicine, Division of Cardiology, School of Medicine, Faculty of Health Sciences, Chris Hani Baragwanath Academic 
Hospital, University of the Witwatersrand, Johannesburg, South Africa
 
Introduction: Obesity predicts the development of heart failure independent of conventional risk factors. We have recently demonstrated in 
a community sample with a high prevalence of obesity that waist circumference has a strong and inverse relationship with early-to-atrial 
transmitral velocity (E/A), an index of diastolic function of the left ventricle (LV). The mechanisms that account for this relationship are unclear. 
Metabolic, neurohumoral, inflammatory (adipokines) or haemodynamic (central aortic blood pressures) factors may play a role.
Aims: To determine the relationship between transmitral E/A and indices of insulin resistance, measures of the circulating renin-angiotensin-
aldosterone system (RAAS), the inflammatory marker C-reactive protein (CRP), or central aortic BP in a community sample with a high 
prevalence of obesity.
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Methods: Transmitral E/A and left ventricular mass indexed for height7 were determined using echocardiography in 672 randomly selected 
participants of a community sample of African ancestry, 63% of whom were overweight or obese. Circulating RAAS and CRP concentrations 
were determined using immune radiometric techniques, a 125I radio immune-assay, and a solid phase sandwich ELISA. Central aortic BP was 
assessed using radial tonometry and SphygmoCor software. Insulin resistance was evaluated from the homeostasis model (HOMA-IR) as 
determined from fasting insulin and glucose concentrations.
Results: Independent of a number of confounders including age, gender, pulse rate, conventional diastolic (or systolic) BP, anti-hypertensive 
treatment, left ventricular mass index (LVMI) and the presence of diabetes mellitus or an HbA1c>6.1%; waist circumference was independently 
and inversely associated with E/A (p<0.0005). Similarly, independent of confounders HOMA-IR was independently associated with E/A 
(p<0.01), However, despite CRP being strongly associated with indices of excess adiposity, neither measures of the RAAS, nor CRP were 
independently associated with E/A (p=0.376-0.73) and central aortic BP was not associated with E/A independent of conventional BP.
Conclusion: Insulin resistance may be an indicator, but neither RAAS obesity-associated inflammatory changes nor central aortic BP can explain 
the relationship between obesity and a reduced LV diastolic function beyond conventional cardiovascular risk factors or LVMI.
Improved survival and quality of life after TAVI
Clinton Lloyd, Ian Cox, Rashmi Birla, Sam Melhuish, Tania Riches and Malcolm Dalrymple-Hay
Derriford Hospital, Plymouth, Devon, United Kingdom
Introduction: Transcatheter aortic valve implantation (TAVI) is a new modality of treatment for severe symptomatic aortic stenosis patients 
who are considered to be at high risk for conventional open-heart surgery. The aim of this study was to compare survival with medical therapy 
and open-heart surgery and to assess quality of life (QOL) in patients who underwent TAVI.
Method: 150 patients reviewed for possible TAVI were assigned to TAVI (81), open surgery (13) or medical therapy (56). Additionally, 30 of 
the patients receiving TAVI were interviewed pre-operatively using a questionnaire of 15 questions (designed locally) to compare pre- and 
post- operative quality of life, covering aspects of general health, routine physical functioning and essential daily activities (scoring 0-5).
Results: Overall survival (Log-rank Test p<0.05) for TAVI patients (4 deaths) was better than open surgery (2 deaths) or medical therapy 
(7 deaths). 24 patients completed the QOL survey (12 Male). Mean age 80.29 years (range 56 - 89 years) 2 failed to respond but are known 
to be alive, 2 patients died post-operatively and 2 declined follow-up. Mean scores for General Health (GH), Physical Functioning (PF) and 
Essential Daily Activities (EDA) showed significant improvement post-operatively (39.58 ± 9.23 vs 49.50 ± 7.21) p=<0.001 in TAVI survivors.
Conclusion: In this cohort of the population that tend to have multiple co-morbidities, the overall quality of life improves significantly after 
TAVI. The cost benefit and long term outcome have not been fully assessed in this study, however, TAVI should be considered a viable option 
for patients with severe symptomatic aortic stenosis who are high risk for conventional surgery.
Isolated left ventricular non-compaction (ILVNC): the Chris Hani Baragwanath experience
Nirvarthi Maharaj, Ferande Peters, Farouk Mamdoo, Claudia dos Santos, Hiral Matioda, Elena Libhaber and 
Mohammed R. Essop
Department of Medicine, Division of Cardiology, Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand, 
Johannesburg, South Africa
Introduction: Isolated left ventricular non-compaction (ILVNC) is thought to occur as a result of failure of myocardial compaction during 
embryogenesis. Heart failure, arrhythmias and thrombo-embolism are the cardinal clinical manifestations of this disorder. Published data on 
the clinical and echocardiographic features of ILVNC in Africans is limited. We sought to evaluate the clinical and echocardiographic features 
of African patients with ILVNC.
Methods: This ongoing prospective single centre study enrolled patients attending Chris Hani Baragwanath Cardiac Clinic who satisfied the 
Jenni echocardiographic criteria for the diagnosis of ILVNC. Exclusion criteria were hypertension, coronary artery disease, organic valvular 
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disease and any systemic illness that could contribute to left ventricular dysfunction. The control population comprised 41 age and sex matched 
normal individuals. Transthoracic echocardiography was performed according to the American Society of Echocardiography (ASE) guidelines 
2006 and ASE 2010 guidelines on right heart assessment to determine ventricular structure and function. Clinical and echocardiographic data 
were compared between patients with ILVNC and the control population.
Results: The mean age was 44.25 ± 13.47 years with 56% female in the ILVNC group (n=72). Heart failure was the most frequent clinical 
manifestation of patients with ILVNC and occurred in 70 (97.2%) of subjects. On standard medical therapy which included beta blockers and 
ACE inhibitors most subjects were NYHA 2 (57.1%). The mean left ventricular end diastolic diameter was 59.5 ± 8.33mm with ejection 
fraction 28.16 ± 11.85%. The right ventricle was found to be dysfunctional in 44 (61.1%) of patients with ILVNC with the mean RV S’ (9.32 
± 2.79cm/s) significantly lower than that of the control group. Moderate or severe tricuspid regurgitation was documented in 48 (66.6%) of 
subjects. The systolic pulmonary artery pressure was measured in 62 (86.1%) of subjects with a mean 39.44 ± 9.72mmHg. No echocardio-
graphic features suggestive of ILVNC were noted in a healthy control group of African descent.
Conclusion: ILVNC is not infrequent in the South African Black population. ILVNC in patients of African descent can be characterised by 
biventricular dysfunction and/or isolated left-sided dysfunction and heart failure as a result of systolic dysfunction is the most common clinical 
presentation. 
Left ventricular twist abnormalities in isolated left ventricular non-compaction (ILVNC) 
Nirvarthi Maharaj, Ferande Peters, Elena Libhaber, Claudia dos Santos, Hiral Matioda and Mohammed R. Essop
Department of Medicine, Division of Cardiology, Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand, 
Johannesburg, South Africa
Introduction: Left ventricular twist is defined as the wringing motion of the heart during systole where the LV apex moves in a counter-
clockwise direction while the base moves in a clockwise direction. LV twist is an important factor contributing to the efficiency of the ejection 
of blood during systole. Isolated left ventricular non-compaction (ILVNC) is thought to occur as a result of failure of myocardial compaction 
during embryogenesis. There is a paucity of data assessing myocardial mechanics in African patients with ILVNC. We sought to evaluate left 
ventricular twist mechanics in subjects with ILVNC in whom heart failure as a result of left ventricular systolic dysfunction is the major clinical 
manifestation.
Methods: This prospective single centre study enrolled 72 patients attending Chris Hani Baragwanath Cardiac Clinic between July 2009 and 
December 2011 who satisfied the Jenni echocardiographic criteria for the diagnosis of ILVNC. The control population comprised 39 age and 
sex matched unrelated normal individuals. Parasternal short-axis images at LV basal and apical level were obtained with 3 consecutive end-
expiratory cardiac cycles. Data was transferred to a QLAB workstation (QLAB Advanced Quantification Software version 8.0, Philips) for 
off-line analysis. Clockwise rotation was presented as a negative value and counter clockwise rotation as a positive value when viewed from 
the apex. Peak apical (AR), basal rotation at a time isochronous with peak apical rotation (BR) and Net Twist (defined as the maximal value of 
instantaneous AR–BR) were measured. Rigid body rotation (RBR) was defined as AR and BR occurring in the same direction.
Results: Of 72 ILVNC patients, 31 (43.1%) had a normal twist pattern, while 41 (56.9%) exhibited RBR. In the group with RBR, 27 (65.9 %) 
patients had clockwise rotation and 14 (34.1%) patients had counter-clockwise rotation. In the 31 patients with ILVNC and a normal twist 
pattern, AR (1.75 + 1.45 vs. 4.96 + 2.99) and BR (-1.17 + 1.15 vs. -2.98 + 1.63) as well as net twist (3.1 + 1.71 vs. 7.94 + 3.35) were all 
diminished compared to the control group (p<0.0001). 
Conclusion: LV twist mechanics is impaired in African patients with ILVNC. RBR occurs in 56.9% of patients and can be either in a clockwise 
or counter-clockwise direction. 
182
Twist mechanics in African hypertension patients with systolic dysfunction: an analysis 
using speckle tracking echocardiography
Nirvarthi Maharaj, Ferande Peters, Elena Libhaber and Mohammed R. Essop
Department of Medicine, Division of Cardiology, Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand, 
Johannesburg, South Africa
Introduction: Speckle tracking evaluating twist mechanics has emerged as a sensitive quantitative technique in assessing left ventricular (LV) 
function. LV twist describes the net rotational difference of the apex with respect to the base of the heart and has an important role in LV 
function. Hypertension associated changes in LV twist have not been previously evaluated in African patients with LV systolic dysfunction in the 
absence of coronary artery disease. This study evaluates LV twist dynamics in African hypertensive patients with systolic dysfunction. 
Methods: 41 consecutive hypertensive patients (HTLEF) from the Chris Hani Baragwanath Cardiac clinic between January 2011 to January 
2012 with ejection fraction less than 45% on echocardiography and normal coronary angiography were recruited. The inclusion criteria were: 
sinus rhythm, age >30, no diabetes and normal renal function. The control population comprised 41 normal individuals. To optimise speckle 
tracking, two-dimensional gray-scale harmonic images were obtained at a frame rate of 60 to 80 frames/s. Parasternal short-axis images at LV 
basal and apical level were obtained with 3 consecutive end-expiratory cardiac cycles. Data was transferred to a QLAB workstation (QLAB 
Advanced Quantification Software version 8.0, Philips) for off-line analysis. Clockwise rotation was presented as a negative value and counter 
clockwise rotation as a positive value when viewed from the apex. Peak apical (AR), basal rotation at a time isochronous with peak apical 
rotation (BR) and Net Twist (defined as the maximal value of instantaneous AR–BR) were measured. 
Results: In the HTLEF group, the mean age was 55.0 +/- 9.1 years with 22 (54%) females. The HTLEF patients had a mean duration of 
hypertension of 12.2 +/- 6.5 years with 3.2 +/- 1.6 years of heart failure. Ejection fraction in the HTLEF group was 33.0 +/- 7.6%. LV twist and 
rotation at apical and basal planes were lower in patients with (HTLEF) (1.89 +/- 0.99 vs. 7.15 +/- 2.26; p<0.0001 for AR; -1.44 +/- 0.78 vs. 
-3.75 +/- 1.61; p<0.0001 for BR; 3.3 +/- 1.17 vs. 10.9 +/- 2.7; p<0.0001 for NET TWIST) compared to the control group. 
Conclusion: Left ventricular twist is diminished in African hypertensive patients with systolic dysfunction. The twist is reduced as a result of 
both diminished apical and basal rotation. 
Defensive active coping (AC) facilitates time-domain HRV and sub-clinical 
vascular disease: the sympathetic activity and ambulatory blood pressure in 
Africans (SABPA) study 
Leoné Malan*, Mark Hamer#, Markus Schlaich†, Gavin Lambert†, Manja Reimann‡, Nancy Frasure-Smith◊, Lisa Uys*, 
Andrea de Kock* and Nico Malan*
*Hypertension in Africa Research Team (HART), North West University, Potchefstroom Campus, South Africa
#Department of Epidemiology and Public Health, University College of London, UK
† Department of Biological Psychology, Neurovascular Hypertension & Kidney Disease and Human Neurotransmitters Laboratories, 
Baker IDI Heart and Diabetes Institute, Melbourne, Australia
‡Department of Neurology, Medical Faculty Carl Gustav Carus, Dresden University of Technology, Germany
◊ Department of Psychiatry and School of Nursing, McGill University, Centre Hospitalier Université de Montréal and Research Centre, 
Montreal Heart Institute, Canada
Objectives: Defensive active coping (AC) responses in urban African males have been associated with vascular responsiveness partly explaining 
autonomic nervous system dysfunction. We therefore aimed to assess if AC responses facilitate early sub-clinical vascular disease via alterations 
in time-domain heart rate variability (HRV). 
Methods: We included 363 African and Caucasian men and women without pre-existing atrial fibrillation, aged 45 ± 9 years. The Coping 
Strategy Indicator stratified ethnic gender groups. We collected B-mode ultrasound carotid intima media thickness far wall (CIMTf), 24h BP and 
time-domain HRV or standard deviation of all NN intervals (SDNN). Overnight fasting blood was obtained. 
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Results: Overall Africans and AC Africans, mostly men, revealed (p=0.05) a poorer lifestyle profile and higher prevalence of hypertensive status 
compared to their Caucasian counterparts. Moderately depressed HRV (SDNN <100ms) was prevalent in 32% of Africans compared to 15% 
of Caucasians. A similar trend was shown for the AC African participants (32%) in comparison to Caucasians (16%). Depressed HRV was 
associated with 24h SBP and DBP in AC African men only. Only their SBP values predicted structural vascular changes. 
Conclusion: Depressed HRV was associated with increased 24h BP in AC African men and women. Defensive AC facilitated autonomic 
nervous system dysfunction, acting as a hyperkinetic driving force for increased 24h SBP and early sub-clinical vascular changes in the Africans.
 
The utility of transoesophageal echocardiography in young stroke patients: 
insights from TORCH
Farouk Mamdoo, Ferande Peters, Anupa Patel, Hiral Matioda, Samantha Govender and Mohammed R. Essop
Department of Medicine, Division of Cardiology, Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand, 
Johannesburg, South Africa
Background: The prevalence of a cardiac source for cerebral embolism in young stroke patients in South Africa is unknown. Prior publications 
have documented greater frequency of stroke in young patients with HIV and the frequency of cardiac abnormalities in these patients is unclear. 
Transoesophageal echocardiography (TEE) with contrast enhancement has a high sensitivity for detecting potential cardiac sources of cerebral 
embolism. The Transoesophageal Registry of Chris Hani Baragwanath Academic Hospital (TORCH) was established in 2010 and entails 
prospective data collection on all TEE examinations performed at this hospital.
Aim: To examine the prevalence of cardio-embolism with TEE in young patients with acute ischaemic stroke.
Methods: Retrospective analysis of the TORCH data on 64 patients with young stroke (age <40 years) who presented from June 2010 to 
January 2012. Patients were referred for evaluation for possible cardiac source of embolism from within CH Baragwanath Academic Hospital 
and referring hospitals. Inclusion criteria were (1) Confirmed ischaemic stroke on brain imaging (2) No obvious cause for stroke on ECG, 
transthoracic echocardiography, carotid Duplex studies and haematologic evaluation (3) No evidence of meningitis/encephalitis on lumbar 
puncture. HIV status was documented in each patient after obtaining informed consent. All patients underwent transthoracic echocardiographic 
imaging and where no obvious cardiac source was identified they were referred for TEE. TEEs were performed under conscious sedation using 
the X7-2T TEE transducer coupled to a Philips iE-33 machine and all data were analysed on QLAB software linked to an Excelera system. A 
bubble test was performed in all subjects using agitated saline contrast (ASC) via a peripheral vein and recordings taken within an 8 beat cycle 
with either a Valsalva manoeuvre or firm pressure applied over the patient’s abdomen. A positive bubble study was considered positive with 
the appearance of ASC in the left-sided chambers within 4 beats of the infusion in appropriately selected views. 3DTEE was utilised when 
deemed necessary and in particular for viewing the atrial septum.
Results: Of the 64 patients, 53 (83%) tested positive for HIV infection. Overall 5 (8%) patients had a potential source for cardio-cerebral 
embolism: 1 patient had an isolated patent foramen ovale, 2 had small secundum atrial septal defects and 2 had atrial septal aneurysms (1 of 
which had an associated patent foramen ovale). It was unclear whether these defects could clearly be linked to the presenting stroke.
Conclusion: The diagnostic yield of TEE in young stroke patients in a high HIV prevalence area is low. Even in the small number of patients in 
whom structural abnormalities are identified, it remains unclear whether these defects clearly account for the stroke. Based on these findings, 
we cannot recommend routine TEE in young stroke patients in areas of high HIV prevalence.
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Coronary artery disease prevalence amongst patients undergoing valve 
replacement surgery
Ruchika Meel, Ahmed R. Essop, Anthony Becker, Chris Zambakides, Anthony Yip, Richard Nethononda and 
Mohammed R. Essop
Department of Medicine, Division of Cardiology, Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand, 
Johannesburg, South Africa
Introduction: The prevalence of coronary artery disease (CAD) amongst patients presented for valve surgery has important implications for 
routine angiography. According to the 2006 ACC/AHA guidelines on valve disease, coronary angiography is recommended in symptomatic 
men >35 prior to aortic valve replacement; any patient >35 with 2 or more coronary risk factors; asymptomatic men >45; and women >55. 
However, in a large Brazilian study no asymptomatic patient, <60 years, without risk factors was found to have CAD. The prevalence of CAD, 
in predominantly black patients, presented for valve surgery in South Africa has not been published.
Methods: A prospective, descriptive study of patients presented for valve surgery between 2010 and 2011 was performed. CAD was defined 
as stenosis of 70% or greater, in one or more epicardial vessels as defined by quantitative coronary angiography.  
Results: A total of 116 patients were included. Of these 56.9% were female and the mean age was 57.4 years. Black patients represented 
66.4%; Caucasians 19.8%; and, coloured and Indian patients 13.8%. Hypertension and smoking were the most common risk factors (26.7% and 
16.4%, respectively). Diabetes mellitus, dyslipidaemia, chronic kidney disease and prior CAD occurred in 15.5%. The remainder had no known 
risk factors. Angina was present in 18% of patients. New York Heart Association functional Class 2, 3 and 4 patients were distributed as follows: 
54%, 38.8% and 0.7%, respectively. HIV prevalence was 12% - half of them were on anti-retroviral therapy. An isolated valve lesion occurred 
in 69% of patients with the remainder having 2 or more lesions. The most common valve lesion was aortic stenosis (43.1%), followed by mitral 
stenosis (36.2%), aortic regurgitation (29.3%), mitral regurgitation (25.9%) and tricuspid regurgitation (19%). The most common aetiology was 
rheumatic heart disease (58.6%), followed by degenerative valve disease (24.1%). Congenital valve disease, infective endocarditis and ascending 
aorta aneurysms accounted for the remainder (17.2%). CAD was documented in 10 patients (8.6%), of whom 8 had single vessel disease and 
2 had double vessel disease. The age range was 55 to 87. Only one black patient, aged 67, had CAD. None were HIV positive, 4 had preceding 
angina and 4 patients had no risk factors for CAD. 
Conclusion: The prevalence of CAD in patients presented for valve surgery in this study was 8.6%. For asymptomatic, black patients without 
risk factors, the need for routine angiography prior to valve replacement is questionable.
Cardiological family screening in isolated left ventricular non-compaction (ILVNC)
Michael Thamaga Mogogane, Ferande Peters, Claudia dos Santos, Hiral Matioda, Richard Nethononda and Rafique Essop
Department of Medicine, Division of Cardiology, Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand, 
Johannesburg, South Africa
Introduction: Isolated Left ventricular non-compaction (ILVNC) is presumed to be a genetic cardiomyopathy with familial and sporadic forms. 
Familial disease is thought to occur in 15 to 50% of adults. Familial cases of ILVNC display considerable genetic heterogeneity. In Africa there 
is a paucity of data on cardiological family screening among families of patients diagnosed with ILVNC.
Methods: Systematic cardiological screening of first degree relatives of patients diagnosed with ILVNC commenced in December 2011 at the 
Chris Hani Baragwanath cardiomyopathy clinic. First degree relatives were evaluated by 2 clinicians (M.M. and F.P.). Evaluation included a 
medical history, physical examination, electrocardiography and echocardiography. ILVNC was diagnosed based on the Jenni echocardiography 
criteria. Cases with poor echo windows or equivocal echocardiographic features were referred for cardiac MRI.
Results: 35 relatives from 11 families were screened. The mean age of relatives was 26.8 years (range 2 to 73 years), 26 (74%) were female. 
ILVNC was diagnosed in 8 (22.8%) participants from 5 unrelated families. All 8 (22.8%) of the relatives with ILVNC were NYHA 1 and all had 
a normal left ventricular ejection fraction. In all 8 affected individuals the apex and mid lateral walls displayed features of non-compaction. No 
relatives screened displayed echocardiographic features of dilated or hypertrophic cardiomyopathy. Two relatives with equivocal echo-
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cardiographic features for ILVNC were identified and are awaiting elective cardiac MRI. Four (50%) of the 8 affected family members had 
normal electrocardiograms, while the other 4 had nonspecific ST- and T-wave abnormality. 
Conclusion: These preliminary results reveal that cardiological family screening identified ILVNC in 22.8% of relatives, the majority of whom 
were asymptomatic with preserved ejection fraction. More extensive cardiological screening of a larger cohort of ILVNC relatives is required 
to determine more accurately the prevalence of familial involvement. Cases identified as ILVNC during screening require long term follow-up 
to determine the clinical outcome and prognosis of these individuals.
Mortality associated with infective endocarditis (IE)
Jameel Moosa, Ngoba Tsabedze, Ahmed Vachiat, Rohan Ramjee, Thomas Kalk, Keir McCutcheon, Lance Mkhwanazi, Riaz 
Garda and Pravin Manga
Division of Cardiology, Charlotte Maxeke Johannesburg Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa
Introduction: Infective endocarditis (IE) in the post-antibiotic era is associated with an in-hospital mortality rate of 18 - 23% in well developed 
countries. The mean age of these patients is 60 years mainly due to a higher prevalence of degenerative cardiac disease and a lower incidence 
of rheumatic heart disease (RHD). The aim of our study was to assess the in-hospital mortality rate of infective endocarditis in a busy public 
academic hospital in South Africa.
Methods: A retrospective analysis of all patients with probable or definite IE presenting to CMJAH from 2006 to 2011 was performed.
Results: A total of 101 patients with IE were reviewed. The mean age of this study population was 38 years with 62 males (61%) and 39 
females (39%). The mortality rate in the overall cohort was 28% (28 patients). The mean age of this group was 39.8 years. Blood cultures were 
positive in 14 patients (48.3%), with majority being Staphylococcus aureus (35.7%), Streptococcus viridans (21.4%) and Coagulase negative 
Staphylococcus (CNS) (14.3%). The mitral valve alone was involved in 13 patients (47%), mixed mitral/aortic valve in 8 patients (28%), isolated 
aortic valve in 5 patients (18%) and 2 patients (7%) had isolated tricuspid valve (TV) endocarditis. Fifteen (54%) of these patients had RHD, 
4 (13.8%) had degenerative valves, 1(3.4%) had MV prolapse, 2 (7%) had prosthetic valves and 6 (21%) had no predisposing valve pathology. 
Of the 73 surviving patients, the mean age was similar at 36.9 years. Blood cultures were positive in 28 patients (38%), with the majority being 
Streptococcus viridans (35.7%), Staphylococcus aureus (14.3%) and CNS (10.7%). The mitral valve alone was involved in 34 patients (46%), 
isolated aortic valve in 18 (25%), mixed mitral/aortic valve in 16 patients (22%) and 5 patients (7%) had isolated TV endocarditis. The majority 
45 (61%) of these patients had RHD.
Conclusion: The mortality rate of IE in our unit over the last 6 years is higher than that found in developed countries. The mean age of our 
patients is significantly younger as RHD is still the most prevalent predisposing factor. Staphylococcus aureus endocarditis was significantly more 
prevalent among non-survivors.
 
Invasive haemodynamic evaluation of category 1 pulmonary arterial hypertension (PAH)
Muhammad Zaid Moosa*, Paul Williams#, Ahmed R. Essop* and Mohammed R. Essop*
* Department of Medicine, Division of Cardiology, Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand, 
Johannesburg, South Africa
#Pulmonary Hypertension Research Group, Division of Cardiology, University of Witwatersrand, Milpark Hospital, Johannesburg, South Africa
Introduction: Pulmonary arterial hypertension (PAH) is a rare disorder which may be fatal if not diagnosed early. The haemodynamics of PAH 
have not been well documented in South Africa and no data on vasoreactivity testing exists. 
Aim: To document in detail the invasive haemodynamic indices in 14 patients referred for investigation of category 1 PAH.
Methods: Patients with confirmed category 1 PAH were included in the study. A right and left heart catheterisation was performed together 
with measurement of cardiac output using the Fick method. Vascular resistances were calculated and response to Nitric Oxide evaluated. A 
positive vasodilator response was defined as a 20% reduction in mean Pa pressure to an absolute value of <40mmHg. 
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Results: The mean age of the cohort was 37.6 ± 12.6 years. The etiology of PAH in the group was found to be idiopathic in 11 patients 
(78.6%), HIV associated in 2 patients (14.3%) and secondary to a congenital shunt in 1 patient (7.1%). The mean PA pressure for the group 
was markedly elevated (103/46/68mmHg) with significant reduction in cardiac index (2.1 ± 1.1 L/min/cm2). Pulmonary vascular resistance was 
high (18 ± 10 Wood units) and although it decreased following NO (14 ± 12 Wood units), there was no significant change in the ratio of 
PVR:SVR (0.72 ± 0.28 pre versus 0.66 ± 0.3 post). Only 1 patient was classified as a responder to NO. 
Conclusion: Patients in this study presented with advanced pulmonary arterial hypertension and the majority showed no reversibility to Nitric 
Oxide. These data would indicate a need for greater awareness and earlier referral to specialised centres in order to improve the outcome in 
these patients. 
The distribution of conventional pulsed wave-tissue Doppler imaging measurements of 
the right ventricle by age and sex in a healthy Black South African population
Muhammad Zaid Moosa, Ferande Peters, Nirthi Maharaj and Mohammed R. Essop
Department of Medicine, Division of Cardiology, Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand, 
Johannesburg, South Africa
Introduction: Because of its complex shape and marked load dependence, the study of the RV remains challenging. Pulse wave tissue Doppler 
imaging (PW-TDI) of the lateral tricuspid annulus allows non-invasive quantitative assessment of RV systolic and diastolic function in several 
cardiac disorders and has a good correlation with invasive haemodynamic indices and RV ejection fraction by CMRI. Small population-based 
studies in the Western world have been undertaken to determine reference values of RV myocardial function using tissue Doppler imaging in 
healthy individuals. Currently there are no normative reference values for these clinically important parameters in patients of African ethnicity. 
Aim: To determine PW -TDI measurements of the RV in a healthy black South African cohort. 
Methods: A total of 100 healthy subjects aged 18 to 64 years with normal left and right sided chamber dimensions and function assessed by 
echocardiography were evaluated. The subjects were subsequently divided into 3 age groups: 18 to 29, 30 to 44 and >45 years. PW-TDI was 
measured from standard apical 4-chamber views by sampling at the junction of the RV free wall and insertion point of the tricuspid leaflets to 
the lateral RV annulus according to ASE/EAE recommendations. All studies were performed by 2 experienced sonographers and measurements 
of myocardial Systolic velocity (S`), Early diastolic velocity (E`) and Atrial diastolic velocity (A`) were interpreted offline by a single cardiologist.
Results: The mean age of the cohort was 37.45 ± 12.32 years of whom 68% were female. Averaged PW-TDI values for the entire population 
were S’ - 12.84 ± 2.3; E’ – 11.61 ± 3.4 and A’- 10.74 ± 3.3cm/s. Analysis of PW-TDI for the 3 age groups revealed the following: With an 
increase in age the S` decreased (R value: 0.41, p=0.69), the A` increased (R value: 0.41, p=0.001), and the E` decreased (R value: -0.35, 
p=0.001) – the latter two showing moderate correlation and statistical significance. 
Conclusion: The reference ranges presented for TDI parameters S`, E` and A` velocities in Black South African individuals will help standardise 
the assessment of RV function by tissue Doppler echocardiography and have implications in diagnosing RV dysfunction in these patients. A 
correlation exists between age and diastolic TDI velocities.
Non-ST elevation myocardial infarction (NSTEMI) in 3 hospital settings in South Africa. 
Does level of care influence management and outcome? A retrospective cohort study
J. Moses*, A.F. Doubell*, P.G. Herbst*, K.J.C. Klusmann# and H.S.V.H. Weich*
*Division of Cardiology, Department of Medicine, University of Stellenbosch and Tygerberg Hospital, South Africa
#Department of Medicine, Worcester Hospital, Worcester, South Africa
Introduction: International guidelines state that patients presenting with an acute coronary syndrome (ACS) without ST-elevation but with 
raised markers of myocardial damage (NSTEMI) should receive early angiography and revascularisation if possible. Current guidelines for 
the secondary hospitals in the Western Cape dictate that patients with NSTEMIs be admitted for conservative medical management and 
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only referred for early angiography if haemodynamically unstable or experiencing ongoing ischaemia (chest pain or dynamic ECG changes). 
Troponins are taken for prognostication 6 - 12 hours after the index event. The aim is to identify a group of very high risk patients who are 
referred for early angiography. The remaining patients receive standard medical treatment and if they remain stable and do not reveal increased 
risk during pre-discharge risk-stratification, are referred to the tertiary centre as outpatients for possible angiography. We aimed to record if 
patients presenting to secondary hospitals are less likely to receive early invasive management and to determine if this exposed some patients 
to increased risk.
Methods: A retrospective cohort study was conducted assessing adult patients presenting with NSTEMIs to Tygerberg Hospital (TBH), Karl 
Bremer Hospital (KBH) and Worcester Hospital (WH) over a one-year period from September 2010 to August 2011. The data was analysed 
as 2 cohorts, a secondary hospital cohort (KBH and WH) and a tertiary hospital cohort (TBH). Where differences were found between the 
2 groups, a sub-analysis was done comparing the WH group and the KBH group.
Results: The TBH and secondary hospital groups were similar in terms of baseline characteristics and clinical presentation. The management 
of the 2 groups differed in that those cases presenting to TBH were more likely to receive early ß-blockade (67% vs 35%, p=0.0055) and 
in-patient coronary angiography (94% vs 51%, p=<0.0001). There was no difference in management between the KBH and WH groups in 
sub-analysis. The TBH patients had a better in-patient mortality (6% vs 23%, p=0.0326) than the secondary hospital group.
Conclusion: This study confirmed our hypothesis that management of a NSTEMI differs between hospitals in the public health sector depending 
on the level of service to which the patient first presents.
The role of novel protein-protein interactions in the function and mechanism of the 
sarcomeric protein, myosin binding protein H (MyBPH)
Jacoba Martina Mouton*, Johanna C. Moolman-Smook# and Craig J. Kinnear#
*Department of Biomedical Sciences, Faculty of Health Sciences, University of Stellenbosch, South Africa
# University of Stellenbosch Medical Research Centre (US/MRC), Centre for Molecular and Cellular Biology, 
Department of Biomedical Sciences, University of Stellenbosch, South Africa
Introduction: Left ventricular hypertrophy (LVH) is acknowledged as a major risk factor for cardiovascular morbidity and mortality and is a 
feature of many common diseases, such as hypertension and diabetes. It is therefore, important to understand the underlying mechanisms 
influencing the development of hypertrophy. Hypertrophic cardiomyopathy (HCM) has been viewed as a model disease in which to study the 
causal molecular factors underlying isolated cardiac hypertrophy. HCM is a heterogeneous disease that manifests with various phenotypes and 
clinical symptoms, even in families with the same genetic defects. HCM is classically described as a disease of the sarcomere, which, as part of 
myofibrils, constitutes the contractile elements in cardiac muscle. One of the regions of the sarcomere that has been identified as playing a key 
role in the regulation of contractility is the C-zone. Identifying binding partners of one of the C-zone proteins, myosin binding protein C 
(MyBPC), has led to insights into the function of this protein. However, myosin binding protein H (MyBPH) is another member of the myosin 
binding protein (MyBP) family, located within this region, of which very little is known. 
Given the sequence homology and similarity in structure between MyBPC and MyBPH, and since both proteins are known to bind myosin, we 
propose that MyBPH may play critical roles in the structure and functionality of the cardiac sarcomere and possibly in HCM pathogenesis. 
Methods: The present study reports the identification of interacting partners of MyBPH with the aim to identify the role of this protein in the 
sarcomere, using yeast two-hybrid (Y2H) analysis. 
Results: Twelve interacting partners were identified of which 3 (SUMO-conjugating enzyme UBC9, alpha cardiac actin (ACTC), myosin 7 
(Myh7)) were considered putative physiological interactors based on the plausibility of the interactions as assessed in silico. These interactions 
will be verified using a number of independent molecular techniques that co-immunoprecipitation and three-dimensional, live cell fluorescence-
based co-localisation.
Conclusion: The results of this study provide important clues to the function of MyBPH and, in so doing, improve our knowledge and 
understanding of this protein’s role in the cardiac sarcomere.
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Assessing the effect of a hypertrophic cardiomyopathy causing mutation in cardiac 
Troponin I on the binding affinity of two known interactors of cardiac Troponin I
Annika Neethling*, Jacoba Martina Mouton* and Craig Kinnear#
*Department of Biomedical Sciences, Faculty of Health Sciences, University of Stellenbosch, South Africa
# University of Stellenbosch Medical Research Centre (US/MRC), Centre for Molecular and Cellular Biology, 
Department of Biomedical Sciences, University of Stellenbosch, South Africa
Introduction: Cardiac troponin I (cTnI), encoded by the sarcomeric gene TNNI3, is known to be the inhibitory component in the troponin 
complex and bind to cardiac actin (ACTC) and cardiac troponin C (cTNC) in the sarcomere. This subunit (cTNI) is essential in controlling 
heart muscle contraction in association with intracellular calcium ion levels. Previous studies have provided evidence that mutations in TNNI3 
lead to the development of Hypertrophic cardiomyopathy (HCM), an autosomal dominantly inherited cardiac muscle disease that is becoming 
more common among the general population, affecting 1:500 individuals. In a recent investigation, we identified a novel HCM- causing mutation 
in the cardiac troponin I (cTNI) encoding gene (TNNI3). This mutation resulted in the substitution of a Leucine for a Histadine at amino acid 
144 (L144H) which is located in the inhibitory region of cTNI. This region contains binding sites for both ACTC and cTNC. The aim of the 
present study is to investigate whether the L144H mutation has any effect on the ability of cTNI to bind ACTC and cTNC.
Methods: Yeast-two-hybrid (Y2H) based ONPG Quantitative ß-Galactosidase assays were used to assess the binding affinity of both wildtype 
and mutant cTNI (L144H) constructs for its known protein interactors, ACTC and cTNC. Statistical analysis was performed using the Graphpad 
PrismTM statistical software package. 
Results: The results indicated that the L144H mutation significantly strengthened the interaction between cTNI and ACTC (p=0.0002), 
suggesting that the mutation may result in a more tightly assembled sarcomere, which could lead to significant impairment of function. No 
significant difference was observed for the binding affinity of wildtype and mutant constructs to cTNC (p=0.6077). 
Conclusion: In the present study in vitro experiments demonstrated that the binding of cTNI to ACTC is significantly increased, which may 
lead to a decrease in the inhibition of cardiac contraction. We conclude that the L144H mutation may cause HCM through impaired relaxation 
rather than impaired contraction.
The role of the novel biomarker ST2 as a marker of left ventricular remodelling in a 
native African Hypertensive Cohort
Dike Ojji*, L. Lacerda#, S. Lecour#, M. Adeyemi Billyrose† and K. Sliwa#
* Hatter Institute for Cardiovascular Research in Africa: Cardiology Unit, Department of Medicine, University of Abuja Teaching Hospital, 
Gwagwalada, Abuja.
# Hatter Institute for Cardiovascular Research, Department of Medicine, Groote Schuur Hospital and the University of Cape Town, 
South Africa 
†Department of Medical Laboratory Sciences, University of Abuja Teaching Hospital, Gwagwalada, Abuja
Introduction: Although brain natriuretic peptide levels has been shown in our native African Hypertensive Cohort to differentiate hypertensive 
left ventricular hypertrophy (LVH) without heart failure (HF) from hypertensive HF due to systolic and/or diastolic dysfunction, it has not been 
very helpful in differentiating hypertensive subjects with LVH from those without. There is therefore the need to look for other biomarkers 
that can effectively do this. 
Objectives: We therefore decided to study the role of the novel biomarker ST2 in differentiating the different spectrum of hypertension 
(hypertension without LVH from hypertensive LVH, and hypertensive LVH from hypertensive heart failure) in some of our 200 Nigerian 
hypertensive cohorts.
Methods: It is a prospective cohort study echocardiography was performed on all subjects. Measurements taken include left ventricular 
dimensions and transmitral pulse wave Doppler flow. LVH was considered present when left ventricular interventricular septal wall thickness 
in diastole and/or left ventricular posterior wall thickness in diastole exceeded 13mm. Plasma ST2 was measured using electrochemiluminescence 
type immunoassay. 
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Results: Preliminary data on a subgroup of 40 subjects studied will be presented. 53.3% were female, 46.7% were male and mean age 
was 49.9 ± 11.5 years. There was significant difference in the ST2 levels between hypertensive subjects with LVH and those without 
(49.7ng/ml±36.2ng/ml versus 23.2ng/ml ± 11.7ng/ml, p-value=0.003). There was also a significant difference when the ST2 levels of those 
with hypertensive HF was compared with that of those with hypertensive LVH (197.3ng/ml ± 68.1ng/ml versus 49.6ng/ml ± 36.3ng/ml, 
p-value=0.000).
Conclusion: Plasma ST2 levels appear to be a very useful marker in differentiating the different spectrum of hypertension-hypertensive heart 
disease-hypertensive heart failure, and may hold a future role in this regard.
Persistence of escape rhythm in chronically paced patients with permanent complete 
heart block
Andrzej Okreglicki and Luzaan Papenfus
Cardiac Clinic, University of Cape Town, Groote Schuur Hospital, Observatory, South Africa
Introduction: The most recent World Society of Arrhythmias’ survey published in 2011 shows that in South Africa the implantation of 
pacemakers is steadily increasing by 7% annually. In Groote Schuur Hospital the majority of pacemakers are implanted for AV block (69%). In 
patients with permanent complete heart block, it is the presence of an escape rhythm that determines patient survival before pacing can be 
implemented. It is said that a ventricular or wide complex escape rhythm is less reliable than 1 originating from the AV junction. With the 
increasing number of pacemakers, there is a greater workload on the “cathlab”. At the time of pacemaker box replacement, as for battery 
depletion, prior knowledge of the persistence of an escape rhythm is useful because if absent, a temporary pacemaker with transvenous lead 
is needed to cover the patient for the short time of disconnection of the permanent pacemaker.
Aim: To determine the persistence of an underlying escape rhythm in chronically paced patients at =3 months after pacemaker implantation.
Methods: A retrospective review of pacing and routine follow-up records of patients of the Arrhythmia Clinic at Groote Schuur Hospital 
determining specifically whether an escape rhythm was found when the pacemaker was either transiently turned off or slowed down. 
Results: Preliminary data included only patients with pacemaker implantation in 2011. Complete records, ECGs and pacemaker follow-up 
details were available in only 48 patients. 46% were males, 54% females with ages: 69.0 ± 10.5yrs (range: 42 - 91yrs). All the patients had an 
escape rhythm before pacemaker implantation: it was AV junctional/ narrow in 31% and wide/ventricular in 69%. At follow-up 78.2% of the 
patients who initially presented with a narrow escape still had an escape rhythm vs 63.3% of the initial wide-complex escape group.
Conclusion: Escape rhythms do not persist chronically in all patients who initially had an escape on presentation with complete heart block 
whether the escape rhythm QRS-complexes were narrow or wide.
Evaluation of inflammatory markers in hypertensive patients vs normotensive
E. Paraskevopoulou*, M.Skoura†, B.Geladaki†, E. Kastrinelli#, A. Xanthopoulos*, S.Patsilinakos* and P. Paraskevopoulou†
*Cardiology Clinic, Konstantopouleio General Hospital of Nea Ionia, Greece
#Biochemistry, Konstantopouleio General Hospital of Nea Ionia, Greece
†Hematology Department, Konstantopouleio General Hospital of Nea Ionia, Greece
Introduction: Chronic vascular inflammation plays an important role in the development of essential hypertension and may contribute to the 
target organs damage. Elevated levels of Matrix metalloproteinase enzymes, Myeloperoxidase of white blood cells and IL-6 may play role in 
arterial stiffness and endothelial dysfunction.
Aim: The aim of this study is to evaluate the significance of elevated levels of Matrix metalloproteinase enzyme ( MMP-10) , Myeloperoxidase 
of white blood cells (MPO), Interleukine -6 (IL-6), White blood cells (WBC) and the absolute number of Neutrophils as imflammatory markers 
in hypertensive patients. The elevated levels of these markers may play an important role in endothelial dysfunction and target organ damage. 
Material and methods: 92 hypertensive patients, 36 males and 56 females (aged 66 ± 8.4) and 40 normotensive, 16 males and 24 females 
(aged 43.4 ± 7) were the participants of this study. All the hypertensive patients were treated with anti-hypertensive medications (ACEI, 
angiotensin receptor blockers, beta adrenergic blockers, calcium channel blockers alone or in a combination therapy). The plasma concentration 
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of MMP-10 and IL-6 were measured in an automated immunoassay analyser (Brio of Diachel), the first with an R&D Systems Elisa kit and the 
second with a Biosource Elisa kit. MPO levels were measured in plasma with an enzymatic immunoassay one stage method, Siemens reagents 
in Dimension EXL analyser. From a Full Blood Count measurement (ADVIA 2120 automated hematology analyser) we evaluated the number 
of WBC and the absolute number of Neutrophils.
Results: Plasma levels of MMP-10, MPO and IL-6 were elevated in hypertensive patients vs normotensive patients. The mean and SD of 
these parameters were: MMP-10: 644 ± 289 vs 391 ± 198 (p-value=0.001); MPO: 781.5 ± 41.8 vs 182.9 ± 18.2 (p-value=0.027); IL-6: 
65.3 ± 22.6 vs 33.7 ± 17.6 (p-value=0.000); WBC: 7.6 ± 1.6 vs 7.4 ± 1.7 (p-value=0.66 - NS); Neutrophils (absolute number): 4.3 ± 1.2 vs 
4.3 ± 1.5 (p-value=0.99 - NS). The data analysis was performed with SPSS 16.0.
Conclusion: Matrix metalloproteinases as proteolytic enzymes that degrade the extracellular matrix and basement membrane, MPO and 
IL-6 as important markers of inflammation have increased interest in the investigation of risk factors for cardiovascular diseases. The elevated 
levels of MMP-10, MPO and IL-6 in hypertensive patients may play an important role in the damage of target organs due to hypertension.
Red blood cell distribution width (RDW) as a new biological marker of heart failure - 
correlation with brain natriuretic peptide (BNP) 
E. Paraskevopoulou*, A. Xanthopoulos*, I. Stergiou#, E. Kastrinelli#, M. Skoura†, H.Theofanakis†, P. Paraskevopoulou† and 
S.Patsilinakos*
*Cardiology Clinic, Konstantopouleio General Hospital of Nea Ionia, Greece
#Biochemistry, Konstantopouleio General Hospital of Nea Ionia, Greece
†Hematology Department, Konstantopouleio General Hospital of Nea Ionia, Greece
Introduction: Recent studies show a growing interest in RDW, a simple parameter of the standard full blood count, whose elevated levels 
seem to have prognostic value in patients with heart failure (HF) correlating with poor prognosis and high mortality rates.
Aims: The aim of this study is to investigate the RDW levels in patients with HF (NYHA = 2) and the correlation with the BNP levels 
Design - method: The study included 215 patients, 142 males and 73 females, aged from 50 to 74 years which were distributed into 3 study 
groups: group A (n:86) consisted of patients with HF due to valvulopathies, group B (n:99) patients with ischaemic cardiomyopathy and group 
C (n:30) patients with HF, atrial fibrillation and hypertensive cardiomyopathy. BNP levels were measured in all patients and RDW were 
obtained as part of the complete blood count. Patients with anaemia (heterozygous b-thalassaemia, iron deficiency anaemia, folic acid or 
vitamin B12 deficiency, bleeding) were excluded from this study. A total of 17 patients were excluded from this trial, 7 patients from group A, 
6 patients from group B and 4 patients from group C. RDW levels were measured in all 3 groups in correlation with the BNP levels.
Results:The correlation (Pearson coefficient) between RDW/BNP in the 3 groups of patients were: 0.476 in Group A* (n:79); 0.512 in Group 
B (n:93) and 0.061 in Group C(n:26). *Correlation is significant at the 0.01 level (2-tailed).
Conclusion: The study results show significant correlation in the groups A and B between BNP and RDW but there is no correlation in 
group C. RDW is a readily available and inexpensive marker with prognostic value in patients with HF and it could be proved that RDW has 
a diagnostic value in emergency medicine. For better determination of its prognostic value future studies have been programmed including a 
greater number of patients and follow-up was planned for all patients on a 6 months - 1 year basis.
Mitral regurgitation in congenital submitral aneurysm (SMA): a clinical and 
echocardiographic perspective
Anupa Patel, Ferande Peters, Hiral Matioda, Elena Libhaber, Farouk Mamdoo and Mohammed R. Essop
Division of Cardiology, Chris Hani Baragwanath Hospital, University of the Witwatersrand, Johannesburg, South Africa
Introduction: Congenital submitral aneurysm (SMA) is a rare disorder which has a unique appearance, important clinical complications and is 
confined almost exclusively to Africans of Sub-Saharan origin. Mitral regurgitation (MR) is an important accompanying clinical feature.
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Objective: To prospectively document the prevalence and mechanisms of mitral regurgitation in SMA in the modern era of ultrasound imaging.
Methods: Between January 2009 and February 2011, 13 subjects, all of African descent were diagnosed with SMA using 2 dimensional (2D) 
and 3 dimensional (3D) transthoracic and transoesophageal echocardiography. Assessment of MR was performed in accordance with the 
American Society of Echocardiography guidelines on valvular regurgitation. 2D transthoracic echo and tissue motion annular displacement 
(TMAD) were used to detect systolic dyssynchrony of the mitral annulus (MAD).
Results: The mean age was 40.5 years, 8 (61.5%) were female. Most - 10 subjects (76.9%) - were referred for a either an incidental murmur 
or acute heart failure. The mean left ventricular end-diastolic diameter (LVEDD) was 55.8mm and mean left ventricular ejection fraction (LVEF) 
was 55.4%. All subjects had a single aneurysm. The most common location was along the posterior annulus - 6 subjects (46.2%). A pan-systolic 
murmur, grade 2/6 or more was heard in all subjects. 2 subjects (15.4%) had moderate MR while the remaining 11 subjects (84.6%) had severe 
MR. The leaflets appeared morphologically normal in all cases. Restricted motion or tethering of the leaflet segment adjacent to the aneurysm 
occurred in 7 subjects (53.9%), pseudo-prolapse of the P2 segment occurred in 2 subjects (15.4%) while 4 subjects (30.8%) had normal leaflet 
motion. In 2 subjects (15.4%), rupture into the left atrium contributed to the severity of the MR. A further important contributing factor, was 
that in all subjects, the area of the annulus adjacent to the commissure appeared to be defective, with part of the wall of the aneurysm involving 
this area instead of annular tissue. In all subjects, mitral annular dilatation occurred. MAD was noted in 6 subjects (46.2%).
Conclusion: Significant MR is common in SMA and is caused by multiple mechanisms that need to be identified systematically to guide 
surgical repair.
Morphologic assessment of the rheumatic mitral valve
Alfonso Pecoraro, Zaheera Cassimjee, Philip Herbst and Anton Doubell
Division of Cardiology, Department of Medicine, University of Stellenbosch and Tygerberg Hopsital, South Africa
Introduction: The pathophysiological hallmark of rheumatic valve disease is a valvulitis which causes commissural fusion. The sequelae of 
commissural fusion give rise to the morphology and physiology of rheumatic valve disease. This is neglected in the current WHO criteria for 
the diagnosis of subclinical rheumatic mitral valve disease. The recently proposed combined criteria (CC) aim to address this shortcoming, but 
ignore commissural fusion and the secondary morphologic features associated with commissural fusion. We describe the commissures in 
patients with rheumatic and non-rheumatic valve disease and contrast the differences in secondary morphologic features of commissural fusion.
Methods: Patient selection was based on a keyword search of echocardiographic reports and prospective enrolment of the first 15 patients 
fulfilling criteria of each of 4 cohorts. Cohort 1: Mitral Stenosis (MS); Cohort 2: Rheumatic Heart Disease (RHD) as defined by CC but without 
MS; Cohort 3: Dilated cardiomyopathy (DCM) with leaflet restriction due to tethering; Cohort 4: Normal controls. All patients had detailed 
clinical assessment and transthoracic echocardiography. The commissures were assessed both via direct inspection of the commissures and 
assessing secondary features of commissural fusion namely: anterior mitral valve leaflet (AMVL) diastolic bowing, AMVL short axis diastolic 
shape, AMVL to commissure angle during diastole and mitral valve area (planometry). These features were then compared in all cohorts.
Results: Commissural fusion was observed in all Cohort 1 and 2 patients (n=30), with bilateral commissural fusion observed in the majority of 
patients (87%). All patients with commissural fusion had AMVL diastolic bowing. No AMVL diastolic bowing was observed in the dilated 
cardiomyopathy or normal control groups. The vertical commissure separation distance was significantly less in Cohort 1 and 2 compared to 
Cohort 3 and 4 (3.46mm vs. 3.8mm vs. 8.6mm vs. 8.3mm, p=0.01). Compared to Cohorts 3 and 4, Cohort 2 patients had significantly smaller 
mitral valve area (5.68cm2 vs. 5.72cm2 vs. 3.36cm2, p=0.01). 
Conclusion: Commissural fusion and the secondary feature of AMVL bowing during diastole are typical morphologic features of rheumatic 
mitral involvement. Addition of these features should improve the sensitivity and specificity of current criteria for the diagnosis of subclinical 
rheumatic mitral valve disease.
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HDL/Sphingosine-1-phosphate protects SAFEly: a potential role of the mitochondria in 
conferring cardioprotection
Sarah Pedretti*, Damian Hacking*, Miguel A. Frias#, Richard W. James# and Sandrine Lecour*
* Hatter Institute for Cardiovascular Research, Department of Medicine, Groote Schuur Hospital and the University of Cape Town, 
South Africa 
#Clinical Diabetes Unit, Department of Internal Medicine, Medical Faculty, University of Geneva, Geneva, Switzerland
Purpose: High density lipoprotein cholesterol (HDL) and its component sphingosine-1-phosphate (S1P) protect against myocardial infarction. 
Recently the SAFE (survivor activating factor enhancement) pathway involving tumour necrosis factor (TNF) and the transcription factor signal 
transducer and activator of transcription 3 (STAT-3), has been identified as a key signalling pathway in cardioprotection, although the end 
effector remains unclear. Opening of the mitochondrial Permeability Transition Pore (mPTP) is a crucial initiator of cell death in the setting of 
myocardial infarction. We therefore hypothesised that HDL/S1P protect the heart via the activation of the SAFE pathway and the subsequent 
inhibition of mPTP opening.
Methods: Isolated adult cardiomyocytes from wildtype, STAT-3 cardiomyocyte deficient (STAT3 -/-) or TNF deficient (TNF -/-) mice were 
exposed to 2 hours of simulated ischaemia (SI) with/ without pre-treatment with native HDL (400μg/ml) or S1P (10nM). Cell viability was 
assessed using trypan blue staining and mPTP opening was measured using TMRM fluorescence and normalised to the normoxic control.
Results: Cardiomyocyte viability under normoxic conditions was 76.2 ± 2.6%. SI reduced viability to 56.8 ± 3.2% (p<0.01 vs. control). 
Cardiomyocyte viability was restored with S1P (74.9 ± 1.6%) or native HDL (71.2 ± 2.8%) (p<0.001 vs. SI). TMRM fluorescence following 
SI was 71.3 ± 10.5% (p<0.0001 vs. control), and restored to 96.0 ± 2.3% in the S1P group and 79.2 ± 3.6% in the HDL group (p<0.05 
vs. SI). In the STAT3 -/- and TNF -/- mice, no cardiomyocyte viability improvement or restoration of TMRM fluorescence was observed with 
either HDL or S1P. 
Conclusion: Both native HDL and S1P are cardioprotective and our data strongly suggest that this effect is mediated via activation of TNF, 
STAT-3 and subsequent inhibition of mPTP opening.
GST polymorphisms and the risk of early onset coronary artery disease in young 
South African Indians
Alisa Phulukdaree*, Sajidah Khan#, Devapregasen Moodley† and Anil Chuturgoon*
* Discipline of Medical Biochemistry, School of Laboratory Medicine and Medical Science, Faculty of Health Science, 
University of KwaZulu-Natal, Durban, South Africa
#Department of Cardiology, University of KwaZulu-Natal, Durban, South Africa
†Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, United States of America
 
Background: Glutathione-S-transferases (GSTs) detoxify environmental agents which may influence the onset and progression of disease. 
Dysfunctional detoxification enzymes are responsible for prolonged exposure to reactive molecules and can contribute to endothelial damage. 
Endothelial damage is one of the underlying factors in the development of coronary artery disease (CAD). Epidemiological data in SA show 
Indians have the highest mortality rates for CAD followed by mixed race, white and black Africans. Literature shows a strong familial link with 
the history of diabetes mellitus type 2, hypertension and CAD, supporting a genetic basis for the development of the disease.
Aim: This study aimed to assess two common polymorphic variants in GST (GSTP1 and GSTM1), in young patients with CAD. 
Methods: All patients (n=100) were South Africans with Indian ancestry. A corresponding age, sex and race matched control group (n=102) 
was also recruited. The frequency of the GSTP1 A105/G105 and GSTM1 +/0 alleles was assessed by PCR-RFLP and differential PCR, 
respectively. 
Results: The GSTP1 A105/A105 and GSTM1 0/0 genotype occurred at a higher frequency in CAD patients (65% vs. 48% and 36% vs. 18%, 
respectively). A significant association between GSTP1 A105 allele (OR=0.6011; 95% CI=0.3803-0.9503; p=0.0377) and GSTM1 0/0 
(OR=2.593; 95% CI=1.353-4.971; p=0.0043) genotype in CAD was observed. Furthermore, we found a significant association between 
smoking and CAD, and the presence of the respective genotypes together with smoking increases the risk for CAD (GSTP1 A105 RR=1.382; 
95% CI=0.958-1.994; p=0.0987 and GSTM1 null RR=1.725; 95% CI=1.044-2.851; p=0.0221). 
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Conclusion: The high percentage of patients who smoked and presented with the GSTP1 A105/A105 and GSTM1 0/0 genotypes supports 
the theory that GSTs play an important role in CAD. These results support the association of GSTM1 null genotype, the GSTP1 A105 
allelotype and smoking with CAD.
The interaction of common polymorphisms of the lipoprotein lipase and PON1 genes 
with cardiovascular risk factors in the Phoenix community
Rosaley Prakaschandra*, Michelle Gordon# and D.P. Naidoo#
*Department of Cardiology, Inkosi Albert Luthuli Central Hospital and University of KwaZulu-Natal, Durban, South Africa
#Department of Cardiology, Division of Medicine, University of Kwazulu-Natal, Durban, South Africa
Background: We investigated gene polymorphisms related to oxidative stress and dyslipidaemia in a sample of subjects with and without 
metabolic syndrome (MS) from the Phoenix Lifestyle Project. Single nucleotide polymorphisms (SNP) in the Human Paraoxonase /PON1 
(Leu55Met and Gln192Arg SNPs) and LPL genes (N291S and S447 X SNPs) were studied to investigate the associations of these mutations 
with cardiovascular risk factors and risk factor clustering in this sample.
Method: There were 1 419 subjects from the Phoenix Lifestyle Project cohort who were studied for CV risk factor prevalence and clustering. 
Anthropometric measurements were performed, with fasting venous blood samples taken from each subject for glucose, lipid and genetic 
analysis. Genotyping was performed using real-time PCR, allele-specific probes and Melting Curve analysis in a sample of 916 subjects.
Results: The crude prevalence of MS in this sub-cohort, classified according to the IDF criteria was 50% (456/916). The LPL and PON 1 
genotypes were similarly distributed (p=n/s) in subjects with and without MS. There were no subjects observed with the LPL N291S mutation. 
There was a significant interaction between the Gln192Arg genotype and elevated triglyceride (>1.7 mmol/l) levels (p=0.016; OR = 1.356), 
while overweight females (BMI >23kg/m2) tended to have the L55M mutation (p=0.027; OR =1.911) which was identified in 23% of over-
weight females.
Discussion: Although the S447X, L55M and Q192R polymorphisms are common in this population, only the 192Arg and the 55Leu alleles, 
previously associated with reduced protection against lipid peroxidation, predispose to hypertriglyceridaemia in the population and general 
obesity in females. Gene polymorphisms related to the MS risk factors may explain a high predisposition to premature artherosclerosis.
The proper delivery pressure for cardioplegic solution in neonatal cardiac surgery: an 
investigation of biomechanical and structural properties of neonatal coronary arteries
Normunds Sikora, Aris Lacis, Vladimir Kasyanov, Elina Ligere, Valts Ozolins and Lauris Smits
Clinic for Paediatric Cardiology and Cardiac Surgery, Children's University Hospital, Riga, Latvia
Introduction: One of the most important issues in paediatric cardiac surgery is myocardial protection, when the cardioplegic solution mixed 
with oxygenated blood is injected into the coronary arteries via a pump. The general principles underlying the efficacy of cold chemical 
cardioplegic solutions are well established. To maintain an adequate delivery of cardioplegia, the right delivery pressure should be used. 
Neonates have many structural, functional, biomechanic and metabolic differences from adults. It is therefore crucial to administer the 
cardioplegic solution with an adequate amount of delivery pressure. If the pressure is too low or too high, it can lead to severe damage of the 
myocardium. 
Methods: To assess the right delivery pressure of the cardioplegic solution, biomechanical properties of eleven specimens of coronary arteries 
from neonates 12.3 ± 13.7 days old and weight 4.1 ± 0.9kg, retrieved at the autopsies, were investigated and compared with adult arteries. 
Specimens were pressurised from 0 to 200mmHg with the step of 20mmHg, while maintaining the length of the sample in situ. Structural 
damages were investigated afterwards.
Results: There was a rapid increase of strain until the inner pressure reaches 80 - 100mmHg and not as rapid regarding to the stress in the 
arterial wall. When the internal pressure exceeds 100mmHg, the strain of the arterial wall increases much slower but at the same time the wall 
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stress and modulus of elasticity begin to increase rapidly. It means that the structural elements of the arterial wall have been straightened and 
possible damage in the wall of coronary arteries of neonates may appear. These results were compared with the biomechanical properties of 
arterial wall in adults and several differences have been found. Structural investigations show damage to the neonatal coronary artery wall after 
it was being pressurised with an inner pressure >100mmHg compared to the coronary artery of adult.   
Conclusion: Our experimental results show that the delivery pressure of the cardioplegic solution in neonatal coronary arteries should not 
exceed 100mmHg. Higher pressure increases the risk of structural damage to the vascular wall, leading to injury of the myocardium.
Proteomic characterisation of cardiac endothelial cell responses to TNF-Alpha and 
asymmetric dimethylarginine (ADMA) stimulation
Hans Strijdom, Salome Smit, Corli Westcott, Mashudu Mudau and Amanda Genis
Division of Medical Physiology, Department of Biomedical Sciences, Faculty of Health Sciences, University of Stellenbosch, South Africa
Introduction: Harmful stimulation of endothelial cells by TNF-alpha (pro-inflammatory cytokine) and ADMA (competitive eNOS antagonist) 
is observed in cardiovascular risk factor conditions. 
Aim: In this study, we aimed to characterize proteomic responses (mass spectrometry analysis) and selected protein pathways (Western 
blotting) in cardiac endothelial cells subjected to TNF-alpha (5ng/ml; 24h) and ADMA (500uM; 24h) stimulation. 
Method: TNF-alpha and ADMA stimulation resulted in the detection of 141 and 93 newly expressed proteins respectively. Protein expression 
induced by TNF-alpha was associated with increased regulation of cell death, apoptotic mitochondrial changes, and Ras signalling. Conversely, 
TNF-alpha resulted in the loss of the insulin signalling pathway, cell proliferation, calcium-binding, membrane rafts, and endosome function. 
Measurements of eNOS – NO signalling revealed a significant reduction in phosphorylated eNOS / total eNOS ratio (p<0.05); however, no 
changes in NO-production were observed as a consequence. P22-phox expression increased by 25% (p<0.05), suggestive of NADPH-oxidase 
activation. TNF-alpha-induced expression of NF-KB and TRADD proteins, and a reduction in IKB-alpha expression (27%; p<0.05) suggested 
TNFR1-TRADD-NFKB activation. Membrane integrity remained intact (propidium iodide staining). ADMA-stimulation resulted in increased 
ribosomal activity and protein translation, increased expression of apoptotic pathways, increased redox activity, increased cytoskeletal and 
vesicular activity, and increased ATPase function. Conversely, ADMA resulted in the loss of cell morphogenesis and NO synthase binding. The 
phosphorylated/total eNOS ratio was not affected by ADMA, and neither was NO production. NADPH-oxidase activity (p22-phox) was also 
not affected by ADMA, and the NF-KB pathway was not activated (IKB-alpha expression). Despite upregulation of pro-apoptotic protein 
pathways, cell death did not occur (propidium iodide staining). 
Conclusion: The proteome of TNF-alpha stimulated cells showed significant increases in pro-apoptotic protein pathways and pro-oxidative 
stress protein expression, probably mediated via the TNFR1-TRADD-NF-KB pathway. Protective cellular components such as insulin signalling 
and eNOS activation were down-regulated by TNF, although these changes did not result in cell death. Interestingly, our data showed increases 
in protein synthesis, cytoskeletal and vesicular transport mechanisms in ADMA-treated cells, unrelated to its more famous role as an eNOS 
antagonist. Although apoptotic proteins were increased by ADMA, this was not as pronounced as in TNF-alpha-treated cells. This study 
provides a comprehensive characterisation of cardiac endothelial cell proteomic responses to TNF-alpha and ADMA and novel insights into 
the expression of new proteins induced by these stimuli.
Novel sarcomeric hypertrophy modifier proteins that interact with titin in hypertrophic 
cardiomyopathy
Carol Todd, Jacoba M. Mouton, Johanna C. Moolman-Smook and Craig J. Kinnear
University of Stellenbosch Medical Research Centre (US/MRC), Centre for Molecular and Cellular Biology, Department of Biomedical 
Sciences, University of Stellenbosch, South Africa
Introduction: Hypertrophic cardiomyopathy (HCM) is an autosomal dominantly inherited cardiac disorder characterised by left ventricular 
hypertrophy (LVH) and increased risk of sudden cardiac death. LVH is an important predictor of morbidity and mortality and is a feature of 
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complex disorders such as hypertension and diabetes. Since LVH is a primary feature of HCM, this disorder has been considered a model 
disease to study the complex mechanisms leading to LVH. More than 1 000 HCM causing mutations in 19 genes have been identified to date. 
Most causal mutations have been identified in sarcomeric and myofilament associated genes. Interestingly, a large degree of phenotypic 
variability exists across families as well as within families harbouring the same primary HCM-causing mutation. This observation has directed 
the focus of several research endeavours to the identification of possible genetic modifiers of the hypertrophic phenotype. 
Aim: Here, we aim to identify putative HCM-modifying genes by searching for novel interactors of Titin, a protein known to be involved in 
HCM. We hypothesise that proteins that interact with proteins known to be mutated in HCM can be considered potential HCM-causing or 
modifying genes. 
Method: To identify novel Titin-interacting proteins, yeast two-hybrid analysis was performed using the 11 domain super repeat of Titin, found 
in the C-zone, as “bait” because this region of the sarcomere contains several HCM causative genes. 27 possible putative Titin interactors were 
identified and five were selected to be verified further. The putative interactions were confirmed by three-dimensional colocalisation. The most 
promising results are between Titin and Heart-type fatty acid-binding protein 3 (H-FABP3), Phosphatidylethanolamine-binding protein 4 
(PEBP4) and Filamin C (FLNC). The two other interactions were between Titin and Myomesin 1 (MYOM1) and Myomesin 2 (MYOM2). 
The genes encoding these interactors will be used in family-based association studies to determine whether they are potential HCM-
modifying genes. 
Conclusion: The identification of HCM-modifying genes may help researchers better understand the molecular mechanisms involved in the 
development of LVH in HCM as well as in hypertension and diabetes. They will allow for the improved understanding of HCM patho-aetiology 
and may improve risk profiling. 
Baroreceptor sensitivity, cardiovascular responses and ECG left ventricular hypertrophy 
in men: the SABPA study
Lisa Uys*, Leoné Malan*, Johannes van Rooyen*, Faans Steyn#, Tjalf Ziemssen† and Manja Reiman†
*School for Physiology, Nutrition and Consumer Sciences, North-West University, Potchefstroom Campus, Potchefstroom, South Africa
#Statistical Consultation Service, North-West University, Potchefstroom Campus, Potchefstroom, South Africa
†Department of Neurology, Medical Faculty Carl Gustav Carus, Dresden University of Technology, Germany
Introduction: Research has established a significant relationship between hypertension and attenuated baroreceptor sensitivity (BRS), which in 
turn indicates an alteration in autonomic control of the cardiovascular system. Sympathetic hyperactivity has been implicated as one of the 
possible contributing factors to hypertension specifically in black African men. The objective of this study was to compare BRS and cardiovascular 
responses between African and Caucasian men. Associations between BRS, cardiovascular responses, ambulatory blood pressure and left 
ventricular hypertrophy (LVH) were also investigated in these groups. 
Methods: The Sympathetic Activity and Ambulatory Blood Pressure in Africans study (SABPA) included 82 African and 100 Caucasian male 
teachers (aged 20 - 65 years), recruited in the North-West Province, South Africa. Ambulatory blood pressure measurements were conducted 
which was followed the next morning by cardiovascular measurements registered with a Finometer and 12-lead ECG during rest as well as 
stressor exposure (Stroop colour-word conflict and cold pressure test). Spontaneous BRS and Cornell product (marker of LVH) were 
calculated. From the 12-lead ECG, the height of the R-wave in the aVL lead was also observed as marker for increased cardiovascular risk. 
Results: The African men had significantly higher blood pressure (p<0.001) and Cornell product (p=0.026) as well as lower BRS stress 
responses (p=0.012). In this group, attenuated BRS (Adjusted R2=0.59; ß=-0.24; 95% CI=-0.42; -0.06), coupled to an α-adrenergic response 
pattern (Adjusted R2=0.58; ß=-0.84; 95% CI=-1.08; -0.60) was associated with elevation of ambulatory blood pressure. LVH was, however, 
not predicted by a BRS reduction. 
Conclusion: Attenuated BRS, especially during stress is a possible contributing factor to the development or promotion of α-adrenergic driven 
hypertension in our male African group. Coupled to higher RaVL and Cornell product values, the risk for future cardiovascular events may be 
increased.  
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Cardiac presentations of HIV positive patients at Charlotte Maxeke Johannesburg 
Academic Hospital
Ahmed Ismail Vachiat, Riaz Garda, Lance Mkhwanzi, Keir McCutcheon, Thomas Kalk, Rohan Ramjee and Pravin Manga
Division of Cardiology, Charlotte Maxeke Johannesburg Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa
Introduction: South Africa has over 5.6 million people infected with HIV. There is limited knowledge on the impact of the HIV epidemic on 
heart disease in South Africa. Thus the aim of this study was to ascertain the spectrum of cardiac disease in HIV positive patients presenting to 
a busy public academic cardiology unit. 
Methods: HIV positive patients presenting to the Cardiology department at CMJAH over 2 years (2010 and 2011) were reviewed. Data was 
collected with regard to spectrum of cardiac disease, the CD4 count and status of anti-retroviral therapy.
Results: There were 204 HIV positive patients out of 2 500 admissions (8.2%) that presented to the Cardiology unit. The average age was 42 
years with 89 (43.6%) males and 115 (56.4%) females. The most common condition was HIV cardiomyopathy 53 (26%) patients. There were 
39 (19%) patients that presented with valvular heart disease and 34 (18%) patients that presented with pericardial effusions. 23 (14%) patients 
presented with coronary artery disease. 11 patients presented with STEMI and unstable angina and 5 with NSTEMI. 16 (8%) patients presented 
with right heart failure, 10 (5%) patients with hypertensive cardiomyopathy, 6 (3%) with constrictive pericarditis, 7 (4%) with peripartum 
cardiomyopathy, 3 (2%) with infective endocarditis and 7 (3%) with other causes of cardiovascular disease. There were 18 (9%) hypertensive 
patients and 9 (5%) diabetic patients. 57 patients (28%) were diagnosed with Tuberculosis. Only 41 (20%) patients were on anti-retroviral 
therapy on admission. 75% of patients had CD4 count <350 cells/μl. There were 5 (3%) patients with malignancies. Hypertrophic cardio-
myopathy was diagnosed in 4 patients, dextrocardia in 1 patient and left ventricular non-compaction in 1 patient. The majority of patients were 
in sinus rhythm except 3 patients with atrial fibrillation and 1 patient with atrial flutter. One patient presented with Torsades du Pointes.
Conclusion: HIV positive patients present at a young age and are more likely to be female. HIV cardiomyopathy, valvular heart disease and 
pericardial effusions are the most common presentations. This study showed an almost 5-fold higher prevalence of CAD as compared to a 
previous review in 2006 - 2008. The majority (80%) of patients were not on anti-retroviral therapy although 87% of these patients qualified 
for anti-retroviral therapy.
Myocardial twist characteristics in an African chronic kidney disease population on 
haemodialysis before and after dialysis as measured by speckle tracking 
echocardiography
Anthony Yip*, Saraladevi Naicker#, Ferande Peters*, Mduduzi Mashabane#, Elena Libhaber*, Nirthi Maharaj*, 
Samantha Govender*, Hiral Matioda* and Mohammed R. Essop*
*Division of Cardiology, Chris Hani Baragwanath Hospital, University of the Witwatersrand, Johannesburg, South Africa
# Department. of Medicine and Division of Nephrology, Charlotte Maxeke Johannesburg Academic Hospital, University of the Witwatersrand, 
Johannesburg, South Africa
Introduction: Haemodialysis causes variable loading conditions on the heart affecting measurement of ventricular function by ejection fraction. 
Myocardial twist, defined as the ‘wringing’ action of the heart, describes an aspect of myocardial deformation which results in clockwise rotation 
at the base of the heart, and counter-clockwise rotation at the apex. Net twist is the difference between peak apical and basal rotation, and 
represents a novel way to assess myocardial function. In this pilot study, the net twist was measured in an African population before and after 
haemodialysis compared to matched controls.
Methods: Twenty one patients were recruited from the CH Baragwanath Hospital haemodialysis unit. Transthoracic echocardiography was 
performed before and after a single dialysis session using an IE33 system with offline speckle tracking and myocardial twist measurements 
made using the Excelera system (Philips Ltd). Twenty two age and gender matched controls were similarly echoed.
Results: The mean age of the control vs. renal group was 43.77 years and 43.95 years (male: 43% and 41% respectively). Apical rotation was 
significantly diminished in renal patients compared to their controls (5.25o vs. 6.29o, p=0.04), but did not appear to be affected by load 
changes after a single dialysis session (5.25o vs. 5.89o, p=0.12). In comparison, no statistical difference was seen in basal rotation and net twist 
characteristics between renal patients against the control group, nor after dialysis.
Conclusion: Apical rotation is diminished in chronic kidney disease on haemodialysis compared to matched controls, but does not appear to 
be significantly affected by the load changes of dialysis.
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